[go: up one dir, main page]

WO2019078487A2 - Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid - Google Patents

Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid Download PDF

Info

Publication number
WO2019078487A2
WO2019078487A2 PCT/KR2018/010470 KR2018010470W WO2019078487A2 WO 2019078487 A2 WO2019078487 A2 WO 2019078487A2 KR 2018010470 W KR2018010470 W KR 2018010470W WO 2019078487 A2 WO2019078487 A2 WO 2019078487A2
Authority
WO
WIPO (PCT)
Prior art keywords
flushing
flow path
liquid
connection
module
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2018/010470
Other languages
French (fr)
Korean (ko)
Other versions
WO2019078487A3 (en
Inventor
김용현
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180026509A external-priority patent/KR102168021B1/en
Application filed by Individual filed Critical Individual
Priority to CN201880068051.4A priority Critical patent/CN111225709B/en
Priority to US16/757,114 priority patent/US11464898B2/en
Priority to EP18868322.1A priority patent/EP3698842A4/en
Priority to JP2020542512A priority patent/JP6967159B2/en
Priority to IL274030A priority patent/IL274030B2/en
Publication of WO2019078487A2 publication Critical patent/WO2019078487A2/en
Publication of WO2019078487A3 publication Critical patent/WO2019078487A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/04Access sites having pierceable self-sealing members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10Tube connectors; Tube couplings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/24Check- or non-return valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body

Definitions

  • the present disclosure relates to a medical device for the injection of dangerous chemical liquids.
  • a drug solution injecting device for injecting a liquid drug into the patient.
  • the drug solution in the predetermined storage space is introduced into the patient's body through the passage (for example, the inner space of the tube and the injection needle) that is connected to the patient by using the above-described drug solution injector.
  • dangerous drugs are known which have harmful effects on the human body when exposed to the outside air.
  • the above-mentioned dangerous drugs include anticancer agents such as 5-FU.
  • the dangerous chemical liquid is exposed to the outside air of the chemical liquid injecting apparatus when injecting the 'dangerous chemical liquid' (hereinafter referred to as 'dangerous chemical liquid') into the patient by using the chemical liquid injecting apparatus, (Such as doctors, nurses, etc.) due to the fact that they are burnt or vaporized into the respiratory system of the human body.
  • a flow rate control module in which a dangerous drug is injected into the body of a patient at a time and slowly injected into the body for a considerable period of time.
  • the flow rate adjusting module is disposed in the passage of the chemical liquid injecting device to reduce the flow rate of the liquid flowing in the passage.
  • a pathway for example, an inner space of the tube and the injection needle
  • a priming operation for filling a liquid for example, a chemical solution to be injected
  • a predetermined inlet for introducing the priming liquid into the passage is constituted.
  • the inlet is disposed at an upstream portion of the passageway. Accordingly, in the conventional chemical liquid injecting apparatus, the flow rate reduction module is disposed on the downstream side of the inlet.
  • This disclosure may help a medical practitioner to safely and conveniently perform a medical treatment using the dangerous drug.
  • the flushing liquid is introduced through the inlet.
  • the present disclosure solves this problem, helps to complete the flushing step within a short period of time after the flushing step is started, and can reduce the amount of the dangerous chemical solution unnecessarily injected into the patient.
  • the present disclosure can help the priming operation to be performed safely and conveniently.
  • the flushing apparatus for injecting a hazardous chemical solution is configured to connect a connection pipe for guiding a hazardous chemical liquid harmful to a human body when exposed to outside air and a patient connection module for injecting the dangerous chemical liquid into a patient, And a flushing portion for forming a first flow path for guiding the hazardous liquid from the connection tube to the patient connection module and a second flow path connected to a predetermined connection point located between both ends of the first flow path, body; And a flow rate reduction unit arranged on the upstream side of the connection point in the first flow path and configured to reduce a flow rate of the hazardous liquid flowing in the first flow path.
  • the apparatus for injecting a dangerous chemical liquid includes: a pumping module configured to pressurize the dangerous chemical liquid; A connection pipe through which the dangerous chemical liquid flowing out from the pumping module flows according to the pressure in the pumping module; And a flushing device.
  • the main body may include an integrally formed joint part.
  • the joint part may form a connection flow path that is a part of the first flow path connecting the downstream end of the flow rate reduction part to the connection point.
  • flushing device it is possible to safely handle the dangerous drug to the medical staff and the patient, and to improve the convenience of the medical treatment for injecting the dangerous medicine of the medical staff.
  • the joint part when the flushing apparatus is discarded after the flushing operation, the probability of occurrence of a dangerous situation in which the joint part is separated and the internal dangerous chemical liquid is exposed to the outside can be reduced.
  • the joint part does not need to be separated and assembled, it is possible to significantly reduce the probability that infectious substances such as unhygienic foreign substances and viruses are introduced into the flow path.
  • 1A is a conceptual diagram showing an entire system of a dangerous chemical liquid injector 1 according to an embodiment of the present disclosure.
  • 1B is a conceptual diagram showing an entire system of a dangerous chemical liquid injector 1 'according to another embodiment of the present disclosure.
  • FIG. 2 is an elevational view of the flushing apparatus 700 according to the first embodiment of the apparatus for injecting hazardous chemical liquids 1, 1 'of Figs. 1A and 1B.
  • FIG. 3 is a cross-sectional view of the flushing apparatus 700 except for the flushing port opening / closing part 740 cut along the flow path P in FIG. Figure 3 shows a partial enlarged view showing a partial operating mechanism.
  • FIG. 4 is an exploded perspective view of the flushing apparatus 700 in a state where the downstream vent cap 780 is removed in FIG.
  • FIG. 5 is an elevational view of a flushing apparatus 700 'according to a second embodiment of the apparatus for injecting hazardous chemical liquids 1, 1' of Figs. 1A and 1B.
  • FIG. 6 is an exploded perspective view of the flushing apparatus 700 'of FIG.
  • FIG. 7 is an elevational view of a flushing device 700 '' according to a third embodiment of the hazardous liquid injection device 1, 1 'of Figs. 1A and 1B.
  • Fig. 8 is a cross-sectional view of the flushing apparatus 700 "of Fig. 7 taken along the flow path P. Fig.
  • Fig. 9 is an exploded perspective view of the flushing device 700 '' of Fig.
  • FIG. 10 is a cross-sectional view of a flushing apparatus 700 '' 'according to a fourth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1' shown in FIGS. 1A and 1B along a flow path P.
  • FIG. 10 is a cross-sectional view of a flushing apparatus 700 '' 'according to a fourth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1' shown in FIGS. 1A and 1B along a flow path P.
  • FIG. 11 is a cross-sectional view of a flushing apparatus 700 '' '' according to a fifth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1 'shown in FIGS. 1A and 1B along a flow path P.
  • FIG. 11 is a cross-sectional view of a flushing apparatus 700 '' '' according to a fifth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1 'shown in FIGS. 1A and 1B along a flow path P.
  • dangerous chemical liquid means a chemical liquid which is harmful to the human body when exposed to the outside air.
  • the dangerous chemical liquid is a chemical liquid known to adversely affect the human body if it is adhered to the skin of the human body or is vaporized and flows into the respiratory system of the human body.
  • an immobilized liquid such as 5-FU.
  • the apparatus for injecting a dangerous chemical solution (1, 1 ') comprises a pumping module (100) configured to pressurize the dangerous chemical liquid.
  • the apparatus for injecting a dangerous chemical solution (1, 1 ') comprises a connecting pipe (300, 300') for guiding the dangerous chemical liquid. According to the pressure in the pumping module 100, the dangerous chemical liquid flowing out from the pumping module 100 flows through the connection pipes 300 and 300 '.
  • the apparatus for injecting a dangerous chemical solution 1 or 1 ' may include a port module 200 or 200' connected to the connection pipe 300 or 300 'or the pumping module 100.
  • the port modules 200 and 200 ' are configured to be capable of filling liquid (e.g., dangerous drug or priming liquid) into the pumping module 100.
  • the liquid introduced through the port modules 200, 200 ' may be introduced into the pumping module 100.
  • the priming liquid means a liquid that is harmless to the human body even when exposed to the outside air, and can flow into the body.
  • the liquid for priming may be a saline solution.
  • the dangerous chemical liquid injector 1 or 1 ' may include a connection pipe opening / closing module 400 or 400' configured to change whether at least one of the connection pipes 300 and 300 'is open or closed.
  • the apparatus for injecting hazardous chemical liquids 1 and 1 ' may include a filter module 500 for filtering out foreign substances of liquid flowing into the connection pipes 300 and 300'.
  • the apparatus for injecting a dangerous chemical solution (1, 1 ') includes a patient connection module (600, 600') for injecting the dangerous chemical into the patient.
  • the patient connection module 600, 600 ' includes components that are introduced into the patient's body, such as the injection needle 610.
  • the patient connection module 600, 600 ' may include an inlet part including a component to be introduced into the patient's body, such as the injection needle 610, and a remainder part.
  • the lead-in part and the remaining part may be detachably coupled to each other.
  • the inflow part is connected to the patient but is separated from the remaining part, and the user inserts the remaining part into the flushing device 700, 700 ', 700' ', 700' '', 700 " And then joining the lead-in part and the remaining part to each other.
  • the liquid passing through the flushing devices 700, 700 ', 700' ', 700' ', 700 ''''' may be sequentially introduced into the patient's body via the remaining part and the incoming part .
  • the apparatus for injecting a dangerous chemical solution 1, 1 ' comprises a flushing device 700, 700', 700 ", 700 '' ', 700' ', 700 " " ').
  • the flushing devices 700, 700 ', 700' ', 700' '', 700 '''' are connected to the patient connection modules 600 and 600 ' Thereby forming one flow path P1.
  • the flushing apparatus 700, 700 ', 700' ', 700' ', 700'', 700 ''', 700 ''''' includes a second flow path (not shown) connected to a predetermined connection point P1F located between both ends of the first flow path P1 P2.
  • the liquid for flushing can flow into the first flow path P1 from the outside through the second flow path P2.
  • the flushing liquid means a liquid that is harmless to the human body even when it is exposed to the outside air and can flow into the body.
  • the liquid for flushing may be a saline solution.
  • the process of injecting the dangerous chemical liquid into the patient using the dangerous chemical liquid injector 1 or 1 ' may include a priming process, a chemical liquid injection process, and a flushing process, .
  • the step proceeds.
  • priming liquid is filled in predetermined predetermined passageways through which the dangerous chemical liquid flows.
  • exposure of the dangerous chemical liquid to the outside air can be prevented in the priming step by connecting the patient connection module 600, 600 'to the patient or coupling the lead-in part to the remaining part .
  • the predetermined passage includes a connection pipe 300 and 300 'and a flushing device 700, 700', 700 '', 700 '' ', and 700' '' '.
  • the predetermined passage may further include a patient connection module 600, 600 'connected to the flushing device 700, 700', 700 '', 700 '' ', 700' '' '.
  • the chemical liquid injection step is performed.
  • the dangerous chemical liquid flows along the predetermined passage in accordance with the pressure in the pumping module 100. Accordingly, in the early stage of the chemical liquid injecting step, the priming liquid filled in the predetermined passage flows into the patient's body. Thereafter, the dangerous chemical liquid flowing after the priming liquid starts to flow into the patient's body.
  • the flushing step proceeds.
  • liquid for flushing flows into a predetermined intermediate point in the predetermined passage through the flushing apparatuses 700, 700 ', 700' ', 700' '', and 700 '' ''.
  • the introduced flushing liquid pushes the dangerous drug filled in the downstream portion in the predetermined passage in the downstream direction.
  • the dangerous drug which has been filled in the downstream side portion of the predetermined passage, flows into the patient's body.
  • the flushing liquid flowing after the dangerous drug starts to flow into the patient's body.
  • the flushing step may be terminated by separating the patient connection module 600 or 600 'from the patient after the flushing liquid starts to flow into the patient's body, and the injection of the dangerous drug You can complete the process.
  • upstream and downstream used in the present disclosure mean that the pumping module 100 is in fluid communication with the connection pipe 300, 300 ', the flow path P and the patient connection module 600, 600' Is defined based on a direction in which the dangerous chemical flows.
  • arrow directions of arrows F2, F3 and F4 in Figs. 1A and 1B are defined as the downstream direction, and the direction opposite to the downstream direction is defined as the upstream direction.
  • the pumping module 100 includes a chamber 110 configured to receive the hazardous chemical liquid.
  • the chamber 110 forms an internal space with the pressurizing unit 120.
  • the dangerous chemical liquid may be stored in the internal space.
  • the priming liquid may be temporarily stored in the inner space.
  • a discharge port portion 111 through which liquid in the chamber 110 is discharged is formed.
  • the discharge port portion 111 may protrude from the outer surface of the chamber 110.
  • the valve 111a may be disposed in the discharge port portion 111.
  • the valve 111a may be configured to open the discharge port portion 111 when pressed by the module connection portion 350 disposed at the upstream end of the connection pipe 300 or 300 '.
  • the valve 111a may include a swab-able valve 111a.
  • the swabble valve 111a includes a surface forming a hole that is open when pressed from the outside.
  • the swabble valve 111a is configured so that a user can wipe the surface of the swabble valve.
  • the pumping module 100 includes a pressurization unit 120 that pressurizes the liquid within the chamber 110.
  • the pressure unit 120 may be disposed within the chamber 110.
  • the pressing unit 120 includes a pressing surface 122 facing the inner space of the chamber 110.
  • the pressing surface 122 may contact the liquid inside the chamber 110 and push the liquid directly.
  • the pressing surface 122 can pressurize the liquid in the chamber 110 by moving in the predetermined pressing direction Ap1.
  • the pressing surface 122 moves in the opposite direction Ap2 of the pressing direction Ap1.
  • 1A and 1B the position in which the pressing surface 122 and the sliding portion 121 are moved in the opposite direction Ap2 is shown with reference to 120A.
  • the pressurizing unit 120 includes a sliding portion 121 configured to slide and move on the inner surface of the chamber 110.
  • the sliding portion 121 is configured to move integrally with the pressing surface 122.
  • the sliding portion 121 may be configured to prevent liquid in the chamber 110 from leaking between the pressing surface 122 and the inner surface of the chamber 110.
  • the pressurizing unit 120 may include a pressurizing operation portion 123 that provides power to move the pressing surface 122 in the press direction Ap1.
  • the pressurizing portion 123 may be configured to pressurize the liquid in the chamber 110 using volume expansion by gas activation.
  • the pressing operation portion 123 may provide a portion that can be held by the user, so that the user can move the pressing surface 122 in the pressing direction Ap1.
  • the pressing unit 120 can be configured to pressurize the liquid using the elastic force of an elastic body such as a balloon.
  • the pressurizing unit 120 may be configured to pressurize the liquid in the balloon.
  • the port modules 200 and 200 'are configured to be capable of filling liquid into the chamber 110. Liquid can be introduced from the outside into the connection pipe 300 or 300 'or the chamber 110 through the port module 200 or 200'.
  • the liquid can move into the connection pipe 300, 300 '.
  • the connectors 300 and 300 ' may be formed of a flexible material.
  • the apparatus for injecting dangerous chemical liquid 1, 1 ' includes a module connection part 350 connected to the discharge port part 111.
  • the liquid discharged from the discharge port portion 111 through the module connection portion 350 can be introduced into the connection pipes 300 and 300 '.
  • the module connection portion 350 may be configured to be coupled to the discharge port portion 111 by the user.
  • the module connection part 350 may be configured such that it can not be separated by the user in a general manner once it is coupled to the discharge port part 111.
  • the discharge port portion 111 is kept closed by the valve 111a.
  • a part of the module connecting portion 350 presses the valve 111a, and thus the discharge port portion 111 which has been closed is opened.
  • the liquid inside the chamber 110 can be introduced into the connection pipes 300 and 300 'through the discharge port portion 111 in the open state of the discharge port portion 111.
  • the module connection portion 350 may be configured such that when the module connection portion 350 is once coupled to the discharge port portion 111 by the user, the module connection portion 350 can not be separated by the user in a general manner.
  • connection pipe 300, 300 ' may be bonded to the discharge port portion 111 without a separate joining process by a user.
  • a separate valve may not be disposed in the discharge port portion 111.
  • connection and disconnection module 400, 400 ' may be configured.
  • the connection pipe opening and closing modules 400 and 400 ' can press the outside of the connection pipes 300 and 300' to block the flow of the liquid at one point of the connection pipes 300 and 300 '.
  • the connector open / close modules 400 and 400 ' may form a connector insertion groove 400h. A part of the coupling pipes 300 and 300 'is inserted into the coupling pipe insertion groove 400h so that the part of the coupling pipes 300 and 300' can be in the closed state of the passage.
  • the filter module 500 may be disposed in the coupling tube 300, 300 '.
  • the filter module 500 includes a filter casing 510 having both ends connected to the connection pipes 300 and 300 ', respectively.
  • the filter casing 510 forms a passage for continuously connecting the flow paths formed by the connection pipes 300 and 300 'connected to both ends.
  • the filter module 500 includes a filter 520 disposed in the passageway of the filter casing 510.
  • the patient connection modules 600 and 600 ' may be connected to the flushing devices 700, 700', 700 '', 700 '' ', and 700' '' '.
  • the patient connection modules 600 and 600 ' may be releasably coupled to the flushing devices 700, 700', 700 '', 700 '' ', and 700' '' '.
  • the liquid that has passed through the interior of the flushing device 700, 700 ', 700' ', 700' '', 700 ''', 700 '''' may move into the patient connection module 600 or 600 ' have.
  • the patient connection module 600, 600 ' may include an injection needle 610 configured to be infiltrable to the skin of the patient.
  • the patient connection module 600, 600 ' includes a module coupling portion 630 coupled with the downstream portion 713 of the flushing device 700, 700', 700 ", 700 '' ', 700" .
  • the module coupling portion 630 may be detachably coupled to the replacement coupling portion 770 of the flushing device to be described later.
  • Either the module coupling portion 630 or the replacement coupling portion 770 may form a male screw and the other may form a female screw to be engaged with the male screw.
  • Arrows C2 in Figs. 1A and 1B show the coupling / separation direction of the module coupling portion 630 with respect to the downstream portion 713.
  • the patient connection module 600 may be configured such that the injection needle 610, the scan support portion 620, and the module coupling portion 630 are sequentially connected.
  • the liquid flowing out from the downstream portion 713 of the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' sequentially flows in the module coupling portion 630, And the injection needle 610 and into the patient's body.
  • the patient connection module 600 'further includes a patient connector fixation portion 650' connected to the downstream side of the module connector portion 630.
  • the patient connection module 600 'further includes a patient connector 640' connecting the patient connector fixing portion 650 'and the scan support portion 620.
  • the patient connector 640 ' may be formed of a flexible material.
  • the patient connection module 600 ' is formed by sequentially connecting the injection needle 610, the scan support portion 620, the patient connection tube 640', the patient connection tube fixing portion 650 ', and the module coupling portion 630 .
  • the liquid flowing out from the downstream portion 713 of the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' ' is sequentially transferred to the module connecting portion 630, The patient's connection tube 640 ', the scan support 620, and the injection needle 610 and into the patient's body.
  • the inflow part is composed of the injection needle 610 and the scan support part 620, and the remaining part is connected to the module coupling part 630, the patient connector fixing part 650 'and the patient connector 640' ).
  • the flushing apparatus 700, 700 ', 700' ', 700' '', 700 ''' includes a main body 710 forming the first flow path P1 do.
  • the main body 710 forms the second flow path P2.
  • the main body 710 includes an upstream portion 711 forming the upstream passage portion P1a.
  • the main body 710 includes a downstream passage portion P1b forming the downstream passage portion P1b.
  • the main body 710 includes a flushing portion 715 forming the second flow path P2.
  • the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a flushing valve unit 720 coupled to the flushing unit 715.
  • the flushing valve unit 720 is configured to be capable of opening and closing the second flow path P2. According to an embodiment, the flushing valve unit 720 may be releasably coupled to the flushing portion 715.
  • the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a flushing port opening / closing portion 740 detachably coupled to the flushing valve unit 720.
  • Arrows D1 in Figs. 1A and 1B show the engagement / disengagement direction of the flushing port opening / closing part 740 with respect to the flushing valve unit 720.
  • the flushing device 700, 700 ', 700' ', 700' '', 700 '' '' includes a replacement coupling portion 770 removably coupled to the patient connection module 600 and 600 '.
  • the replacement engaging portion 770 is disposed at the downstream portion 713.
  • the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' may further include a downstream vent cap 780 detachably coupled to the replaceable engagement portion 770.
  • the downstream vent cap 780 may be coupled to the replaceable engagement portion 770 interchangeably with the patient connection module 600, 600 '.
  • Arrows C1 in Figures 1a and 1b show the engagement / disengagement direction of the downstream vent cap 780 with respect to the downstream portion 713.
  • the dangerous chemical liquid injector 1 according to one embodiment will be described with reference to the differences from the other embodiments.
  • the port module 200 is disposed on the connector tube 300.
  • the port module 200 includes a first extension portion 210 connected to a downstream end of the first connection portion 310.
  • a first port 210a is formed at the distal end of the first extension 210.
  • the liquid in the first extension 210 can move into the first connection 310 or the liquid in the first connection 310 can move into the first extension 210 through the first port 210a.
  • the port module 200 includes a second extension 220 connected to the upstream end of the second connection 320. And a second port 220a is formed at the end of the second extension 220. [ Through the second port 220a, the liquid in the second extension 220 can move into the second connection 320. [
  • the port module 200 includes an inlet 230 configured to allow liquid to flow from the outside.
  • An inlet port 230a is formed at the end of the inlet 230. External liquid can flow into the inlet 230 through the inlet port 230a.
  • the port module 200 may include a swabable valve 231 disposed at the inlet port 230a.
  • the swabble valve 231 may be configured to open the inlet port 230a when the syringe tip is pressed against the inlet port 230a.
  • the port module 200 includes an inlet port opening / closing portion 240 configured to be detachably coupled to the inlet portion 230.
  • the inflow port opening / closing part 240 covers the surface of the swabble valve 231 in a state where the inflow port opening / closing part 240 is coupled to the inflow part 230, thereby improving the sanitary property of the device.
  • Arrow E1 in FIG. 1A shows the direction of engagement / disengagement of the inlet port opening / closing portion 240 with respect to the inlet portion 230.
  • connection pipe 300 includes a first connection portion 310 connecting the discharge port portion 111 and the first extension portion 210 of the port module 200.
  • the connector 300 includes a second connector 320 connecting the second extension 220 of the port module 200 and the filter module 500.
  • the connection pipe 300 includes a third connection part 330 for connecting the filter module 500 and the upstream part 711 of the flushing device 700, 700 ', 700' ', 700' '', 700 ' ).
  • the connector opening and closing module 400 includes a first opening and closing module 410 that can change whether one point B1 of the first connecting part 310 is open or closed.
  • the connector open / close module 400 includes a second open / close module 420 that can change whether one end B2 of the second connector 320 is open or closed.
  • the priming step the chemical solution injecting step, and the flushing step will be described as follows.
  • the inflow port opening / closing part 240 is separated from the inflow part 230, the first connection opening / closing module 410 blocks the passage (see B1) of the first connection part 310 , The passage of the remaining part of the connection pipe 300 except for the first connection part 310 is opened.
  • the priming liquid when the priming liquid is flowed from the outside to the inlet port 230a, the priming liquid flows into the inlet 230, the second extension 220, the second connection 330, The majority of the connection pipe 300 and the interior of the first flow path P1 are filled with the priming liquid by sequentially flowing the third connection part 330 and the first flow path P1.
  • the flushing valve unit 720 is further separated from the flushing valve unit 720 and then discharged from the outside to the flushing valve unit 720 for priming Liquid can be introduced.
  • the priming liquid flowing into the flushing valve unit 720 sequentially flows through the second flow path P2 and the downstream flow path portion P1b so that the inside of the second flow path P2 is filled with the priming liquid It is filled with liquid.
  • the air in the second flow path P2 can be discharged to the outside through the downstream portion 713.
  • a flushing vent unit 720 may be replaced with a flushing vent unit 720 in place of the flushing valve unit 720 in accordance with a fifth embodiment (see FIG. 11)
  • a portion of the priming liquid that has flowed from the connection pipe 300 into the upstream flow path portion P1a flows into the downstream flow path portion P1b through the upstream flow path portion P1a And the other part flows to the second flow path P2 via the upstream flow path portion P1a (see arrow F6).
  • the air in the second flow path P2 can be discharged to the outside through the flushing cap cap 730.
  • the chemical liquid injection step is performed after the priming step.
  • the inlet port opening / closing part 240 is separated from the inlet part 230
  • the second connection pipe opening / closing module 420 blocks the passage of the second connection part 320
  • the connector opening / closing module 410 is separated from the first connecting portion 310 to open the first connecting portion 310.
  • the flushing port opening / closing unit 740 is coupled to the flushing valve unit 720 to block the flushing port 715a.
  • the dangerous liquid medicine flows into the first connection part 310 through the inflow part 230 and the first extension part 210 when the dangerous liquid medicine is introduced into the inflow port 230a from the outside with reference to the arrow F0.
  • the pressing surface 122 moves in the direction Ap2. Thereafter, the inflow port opening / closing part 240 is coupled to the inflow part 230 to block the inflow port 230a, the second connection pipe opening / closing module 420 is separated from the second connection part 320, ) To an open state.
  • the pressure applying surface 122 is moved in the pressing direction Ap1 with reference to the arrows F2, F3 and F4 so that the dangerous chemical liquid flows through the connecting pipe 300, the flushing devices 700, 700 ', 700' '' ', 700' '' ') and the patient connection module 600, 600', and then flows into the patient's body.
  • the flushing step is performed after the chemical liquid injection step.
  • the flushing liquid can be introduced into the flushing valve unit 720 from the outside.
  • the flushing liquid flowing into the flushing valve unit 720 sequentially flows through the second flow path P2, the downstream flow path portion P1b and the patient connection modules 600 and 600 'with reference to the arrow F5, When the flushing liquid starts to flow into the body, the flushing step ends.
  • the port module 200 ' is disposed on the outer surface of the chamber 110.
  • the port module 200 ' forms a passage connecting the outside of the chamber 110 and the inner space.
  • the port module 200 ' is configured such that liquid can flow into the interior space of the chamber 110 through the port module 200'.
  • the port module 200 ' includes an inlet 230' configured to allow liquid to flow from the outside.
  • An inlet port 230a ' is formed at the end of the inlet 230'. External liquid can flow into the inlet 230 'through the inlet port 230a'.
  • the port module 200 ' may include a swivel valve 231' disposed at the inlet port 230a '.
  • the port module 200 ' includes an inlet port opening / closing portion 240' that is detachably coupled to the inlet portion 230 '.
  • Arrow E1 'in FIG. 1A shows the direction of engagement / disengagement of the inlet port opening / closing portion 240' with respect to the inlet portion 230 '.
  • connection pipe 300 ' according to another embodiment includes a filter upstream connection portion 315' connecting the discharge port portion 111 and the filter module 500.
  • the connector 300 ' includes a filter downstream connection 330 connecting the filter module 500 and the upstream portion 711 of the flushing device.
  • connection pipe opening / closing module 400 ' can change whether the one point B1' of the filter upstream connection portion 315 'is open or closed.
  • the priming step and the chemical solution injecting step will be described as follows.
  • the flushing step of the other embodiment is the same as that of the above embodiment, and the description thereof will be omitted.
  • the inflow port switching part 240 ' is separated from the inflow part 230', and the connection pipe opening / closing module 400 connects the passage B1 'of the filter upstream connection part 315' .
  • the priming liquid flows into the chamber 110 through the inlet 230 '
  • the pressing surface 122 moves in the opposite direction Ap2.
  • the inflow port switching part 240 ' is coupled to the inflow part 230' to block the inflow port 230a ', and the connection pipe opening / closing module 400 is separated from the filter upstream connection part 315' (300) to an open state.
  • the pressing surface 122 is then moved in the pressing direction Ap1 so that the priming liquid passes through the discharge port portion 111, the filter upstream connecting portion 315 '
  • the interior of the connection pipe 300 'and the first flow path P1 is filled with the priming liquid by sequentially flowing the connection part 330 and the first flow path P1.
  • the configuration / method of removing air in the second flow path P2 in the priming step is the same as that in the first embodiment, and a description thereof will be omitted.
  • the chemical liquid injection step is performed after the priming step.
  • the inlet port opening / closing part 240 ' is separated from the inlet part 230', and the connection pipe opening / closing module 400 blocks the passage of the filter upstream connection part 315 '.
  • the inflow port switching part 240 ' is coupled to the inflow part 230' to block the inflow port 230a ', and the connection pipe opening / closing module 400 is separated from the filter upstream connection part 315' (300) to an open state.
  • the pressure applying surface 122 is moved in the pressing direction Ap1 with reference to the arrows F2, F3 and F4 so that the dangerous chemical liquid flows through the connecting pipe 300 ', the flushing apparatuses 700, 700', 700 ' 700 '' ', 700' '' ') and the patient connection module 600, 600', and then flows into the patient's body.
  • the flushing apparatus 700 forms a predetermined flow path P therein.
  • the flow path P includes a first flow path P1 connecting the upstream ends of the connection tubes 300 and 300 'and the upstream ends of the patient connection modules 600 and 600'.
  • the first flow path may be formed in a straight line.
  • the first flow path P1 includes an upstream flow path portion P1a disposed on the upstream side with respect to the connection point P1F and a downstream flow path portion P1b disposed on the downstream side.
  • the upstream flow path portion P1a is a part of the first flow path P1.
  • the downstream flow path portion P1b is a part of the first flow path P1.
  • the upstream passage portion P1a connects from the upstream end of the first flow path P1 to the connection point P1F.
  • the downstream flow path portion P1b connects from the connection point P1F to the downstream end of the first flow path P1.
  • the upstream passage portion P1a may be formed longer than the downstream passage portion P1b.
  • the flow path P includes a second flow path P2 to which one end is connected at the connection point P1F of the first flow path P1.
  • the second flow path P2 connects the connection point P1F with a flushing port 715a to be described later.
  • the second flow path P2 may extend in a direction away from the first flow path P1.
  • the regulating flow path P1a1 is constituted.
  • the upstream flow path portion P1a includes an adjustment flow path P1a1.
  • the control flow path P1a1 is formed by the flow rate reducing section 760. [
  • the control flow path P1a1 performs a function of raising the fluid resistance so as to reduce the flow rate of the liquid flowing therein.
  • the control flow path P1a1 is relatively small in cross-sectional area as compared with other portions of the first flow path P1.
  • the connecting passage P1a2 is formed as another portion of the first flow path P1.
  • the upstream flow path portion P1a includes a connection flow path P1a2.
  • the connection passage P1a2 connects from the downstream end P1E of the flow rate reduction section 760 to the connection point P1F.
  • the downstream end P1E of the regulating passage P1a1 is the upstream end of the connecting passage P1a2.
  • the connecting passage P1a2 is formed by the joint part 710A.
  • the inflow path P1a3 may be constituted as another part of the first flow path P1.
  • the upstream passage portion P1a includes the inflow passage P1a3.
  • the inflow path P1a3 is connected from the upstream port 711a to the upstream end of the control flow path P1a1.
  • the upstream end of the inflow passage P1a3 forms the upstream port 711a.
  • the inflow passage P1a3 may be formed by the cover part 710B.
  • the upstream end of the regulating passage P1a1 may form the upstream port 711a without a separate inflow passage P1a3.
  • the main body 710 includes a joint part 710A forming at least the connection passage P1a2.
  • the joint part 710A can form the downstream flow path portion P1b.
  • the joint part 710A may form at least a part of the second flow path P2.
  • the joint part 710A forms a part of the upstream part 711. [
  • the joint part 710A is integrally formed.
  • the joint part 710A is a single part.
  • the joint part 710A is integrally formed by injection.
  • the joint part 710A is formed not to be detachable unless it is broken. Accordingly, when the flushing apparatus 700 is discarded after the flushing step, the user may accidentally remove the joint part 710A, thereby reducing the risk of occurrence of a dangerous situation in which the dangerous chemical liquid in the inside is exposed to the outside.
  • the joint part 710A is a part to be assembled, the impurities can be introduced into the first flow path P1. Since the joint part 710A is integrally formed, a more hygienic flushing device 700 can be realized have.
  • connection passage P1a2 may be shorter than the downstream passage portion P1b.
  • material cost of the integrally formed joint part 710A can be reduced.
  • the amount of the dangerous chemical solution filled in the connection passage P1a2 in the flushing step can be reduced.
  • the main body 710 includes a cover part 710B coupled to the joint part 710A.
  • the downstream portion of the cover part 710B is inserted into the joint part 710A.
  • One of the joint part 710A and the cover part 710B includes a coupling part 710A1 protruding in the other direction and the other is a coupling corresponding part 710B1 in which the coupling part 710A1 is hooked .
  • a hook-shaped engaging portion 710A1 is formed in the joint part 710A and a groove-like engaging portion 710B1 is formed in which the engaging portion 710A1 is engaged with the cover part 710B.
  • the cover part 710B accommodates the flow rate reducing part 760 together with the joint part 710A.
  • the joint part 710A supports the downstream end of the flow rate reduction part 760.
  • the joint part 710A may include a first seating part 710A2 that forms a step where the downstream end of the flow rate reduction part 760 is hooked.
  • the cover part 710B supports the upstream end of the flow rate reducing part 760.
  • the cover part 710B may include a second seating part 710B2 that forms a step to which the upstream end of the flow rate reducing part 760 is caught.
  • the cover part 710B forms the upstream port 711a.
  • the cover part 710B can form the inflow passage P1a3.
  • the cover part 710B forms a part of the upstream part 711. [
  • the cover part 710B is integrally formed.
  • the upstream portion 711 forms an upstream portion of the connection point P1F among the first flow paths P1.
  • the upstream portion 711 is formed by the joint part 710A and the cover part 710B.
  • the upstream portion 711 forms an upstream port 711a through which the liquid flows from the coupling tubes 300 and 300 '.
  • the downstream portion 713 forms a portion of the first flow path P1 downstream of the connection point P1F.
  • the downstream portion 713 is formed by the joint part 710A.
  • the downstream portion 713 forms a downstream port 713a through which the liquid flows from the first flow path P1 to the downstream side.
  • the downstream portion 713 includes an engagement portion 713b that prevents the replacement engaging portion 770 from being detached from the downstream portion 713.
  • the latching portion 713b may protrude from the outer surface of the downstream portion 713.
  • the upstream side surface of the engaging portion 713b comes into contact with a part of the replacement engaging portion 770 to limit the range of movement of the replacement engaging portion 770 in the downstream direction.
  • the flushing portion 715 forms the second flow path P2. At least a portion of the flushing portion 715 is formed by the joint part 710A.
  • the flushing portion 715 forms a flushing port 715a for introducing the liquid for flushing into the second flow path P2.
  • the flow rate reduction section 760 is configured to reduce the flow rate of the dangerous chemical liquid flowing in the first flow path P1.
  • the flow rate of the liquid flowing through the first flow path P1 when the other conditions are the same is smaller than that of the flushing apparatus in the assumed state in which the flow rate reducing section 760 is not provided, (700).
  • the flow rate reduction unit implemented by a user to change the flow rate may be implemented.
  • the flow rate reduction portion 760 is disposed on the upstream side of the connection point P1F in the first flow path P1.
  • the downstream end of the flow rate reduction portion 760 is inserted into the joint part 710A.
  • the upstream end of the flow rate reduction portion 760 is inserted into the cover part 710B.
  • the flow rate reduction unit 760 includes an adjustment flow path forming unit 761 for forming the adjustment flow path P1a1.
  • the flow rate reducing portion 760 includes a sealing portion 762 disposed between the outer peripheral surface of the control flow path forming portion 761 and the inner peripheral portion of the main body 710.
  • the flow rate reduction portion 760 may include a spacer 763 disposed at the end of the adjustment flow path forming portion 761.
  • the flow rate reduction portion 760 may include a first spacer 763a disposed between the upstream end of the control flow path forming portion 761 and the second seating portion 710B2.
  • the flow rate reduction portion 760 may include a second spacer 763b disposed between the downstream end of the control flow path forming portion 761 and the first seating portion 710A2.
  • the flow rate reduction unit 760 may further include a filter unit (not shown) disposed at the upstream end of the control flow path P1a1.
  • the replacement engaging portion 770 is disposed at the downstream portion 713.
  • the replacement coupling portion 770 is detachably coupled to the patient connection module 600, 600 '.
  • the replacement engaging portion 770 may be releasably coupled to the downstream vent cap 780, which will be described later.
  • the replacement engaging portion 770 may be formed so as to surround the outer peripheral portion of the downstream portion 713.
  • the inner circumferential portion of the replacement engaging portion 770 faces the outer circumferential portion of the downstream portion 713.
  • the replacement engaging portion 770 may include a screw corresponding portion 771 for engaging with the patient connecting module 600, 600 '.
  • the screw corresponding portion 771 may be configured to be coupled to the downstream vent cap 780.
  • the screw corresponding portion 771 may be disposed at the inner circumferential portion of the replaceable engaging portion 770.
  • the replaceable engaging portion 770 may include an engaging portion 772 configured to engage with the engaging portion 713b.
  • the engaging portion 772 may be disposed on the upstream side of the replaceable engaging portion 770.
  • the engaging portion 772 protrudes from the inner peripheral portion of the replacement engaging portion 770 toward the outer peripheral portion of the downstream portion 713.
  • the backflow prevention portion 750 prevents the backflow of the flushing liquid in the direction of the flushing port in the second flow path P2.
  • the backflow prevention part 750 functions as a one-way valve.
  • the backflow prevention portion 750 permits the flow of liquid (inflow flow) that moves from the inside of the second flow path P2 into the first flow path P1, while allowing the flow of the liquid from the inside of the first flow path P1 to the second flow path P2, Thereby blocking the flow of the liquid (flow-out)
  • the backflow prevention part 750 can be implemented to be coupled to and detachable from the flushing part 715.
  • the backflow prevention portion 750 is coupled to the flushing valve unit 720 so that the backflow prevention portion 750 is separated from the flushing portion 715 when the flushing valve unit 720 is separated from the flushing portion 715, And may be implemented to be separated from the flushing portion 715.
  • the backflow prevention portion 750 includes a protrusion 751 protruding in the direction F5 of the inflow flow.
  • the protrusion 751 is formed of a flexible material.
  • a hole 751a is formed at the protruding end of the protrusion 751.
  • the hole 751a is formed for the flushing liquid to pass through.
  • the hole 751a is opened or closed according to the flow direction of the liquid in the second flow path P2.
  • the hole 751a of the protrusion 751 is opened when the liquid in the second flow path P2 flows in the direction of the inflow flow F5. (See FIG. 3), the hole 751a of the protrusion 751 is closed when there is no flow of the liquid in the second flow path P2 or when the liquid is going to flow in the outflow direction F6.
  • the backflow prevention portion 750 includes a seat portion 753 that is seated on the flushing portion 715.
  • the seat portion 753 can be seated in the edge portion of the flushing port 715a.
  • the seating portion 753 supports the projection 751.
  • the center of the seating portion 753 forms a hole and the liquid can move to the hole 751a of the projection 751 through the hole of the seating portion 753.
  • the protrusion 751 may be formed in a conical shape as a whole, so that the vertex portion protrudes.
  • the hole 751a is formed in the vertex portion of the protrusion 751.
  • the protruding portion 751 may include a first oblique surface that inclines and extends with respect to the protruding direction, a second oblique surface that inclines and extends in a direction opposite to the first oblique direction with respect to the protruding direction, And both side surfaces covering both sides of the oblique side. 6 and 9).
  • the first oblique face and the second oblique face meet at the protruding end of the protruding portion 751, and the hole 751a extends along the edge .
  • the flushing valve unit 720 is coupled to the flushing portion 715.
  • the flushing valve unit 720 may be further coupled to the flushing port 715a.
  • the flushing liquid may flow into the second flow path P2 sequentially from the outside through the flushing valve unit 720 and the flushing port 715a.
  • the flushing valve unit 720 includes a flushing valve 722 for changing whether the flushing liquid is opened or closed.
  • the flushing valve unit 720 includes a valve casing 721 that supports the flushing valve 722. [
  • the flushing valve unit 720 may include a swabable valve.
  • the flushing valve 722 includes a surface 722a that forms a hole 722h that is opened when pressed from the outside. 3).
  • the flushing valve 722 is formed of a flexible material. When the tip of the syringe J is pressed against the surface 722a from the outside, the surface 722a is bent and the hole 722h is opened.
  • the flushing port opening / closing part 740 opens / closes the surface 722a from outside.
  • the flushing port opening and closing part 740 covers the surface 722a in a state of being engaged with the flushing valve unit 720.
  • the surface 722a is exposed to the outside in a state where the flushing port opening and closing part 740 is separated from the flushing valve unit 720.
  • the flushing port opening and closing part 740 may have a function of disinfecting the surface 722a while being coupled with the flushing valve unit 720.
  • the flushing valve 722 includes an exposed portion 722b which forms the surface 722a on one side.
  • the hole 722h penetrates through the exposed portion 722b. The flushing liquid that has passed through the exposed portion 722b from the outside can be moved to the flushing port 715a.
  • the flushing valve 722 includes a tube portion 722c that supports the exposed portion 722b.
  • the tube portion 722c forms an inner space and is formed in a tubular shape.
  • the periphery of the exposed portion 722b is fixed to one end of the tube portion 722c, and the other end forms a boundary of the opening at the center.
  • the valve casing 721 receives the flushing valve 722 therein.
  • the valve casing 721 forms an opening for exposing the surface 722a at one end.
  • the other end of the valve casing 721 is coupled to the flushing portion 715.
  • the valve casing 721 includes a unit engaging portion 721b which is engaged with the flushing portion 715.
  • the valve casing 721 includes a pressing portion 721a for fixing the backflow prevention portion 750 in a state of being engaged with the flushing portion 715.
  • the pressing portion 721a presses the seating portion 753.
  • the seat portion 753 is held between the pressing portion 721a and the flushing portion 715 and fixed.
  • the downstream vent cap 780 is detachably coupled to the replaceable engagement portion 770 instead of the patient connection module 600, 600 '.
  • the downstream vent cap 780 is coupled to the replacement engagement portion 770 before the start of the priming step.
  • the downstream vent cap 780 before the chemical liquid injection step can be separated from the replacement engagement portion 770. Only the downstream vent cap 780 is shown in FIGS. 1A-3, and the illustration of the downstream vent cap 780 is omitted in the other figures to avoid redundancy.
  • the downstream vent cap 780 discharges the gas and blocks the discharge of the priming liquid when the priming liquid flows along the downstream portion 713 from the connection point P1F in the first flow path P1.
  • the downstream vent cap 780 includes a vent filter 781 that prevents passage of the priming liquid and allows passage of gas.
  • Vent filter 781 may comprise a hydrophobic filter.
  • the downstream vent cap 780 may include a sponge 782 disposed upstream of the vent filter 781.
  • the downstream end of the sponge 782 is in contact with the vent filter 781.
  • the sponge 782 assists in passing the gas while absorbing the priming liquid.
  • the downstream vent cap 780 includes a downstream vent casing 783 that receives the vent filter 781 therein.
  • the downstream vent casing 783 receives the sponge 782 therein.
  • the downstream vent casing 783 forms a vent hole 783a through which the gas passes.
  • the vent hole 783a is disposed on the downstream side of the vent filter 781. [ The gas in the first flow path P1 flows out of the first flow path P1 sequentially through the sponge 782, the vent filter 781 and the vent hole 783a.
  • the downstream vent cap 780 includes a downstream vent cap engaging portion 784 coupled with the replaceable engagement portion 770.
  • the downstream vent cap coupling portion 784 may be formed in a cylindrical shape.
  • the downstream vent cap engaging portion 784 is connected to the upstream side of the downstream vent casing 783.
  • a screw 785 may be formed on the outer peripheral portion of the downstream vent cap coupling portion 784.
  • the screw 785 is formed to engage with the screw corresponding portion 771 of the replacement engaging portion 770.
  • flushing apparatus 700 according to the first embodiment described above with reference to Figs. 2 to 4 will be given to flushing apparatus 700 'according to the second to fifth embodiments described later with reference to Figs. 5 to 11, , 700 '', 700 '' ', 700' '' ').
  • the flushing apparatus 700 is a flushing apparatus that forms a second flow path P2, for example, at an acute angle with respect to the first flow path P1, (715).
  • the second flow path P2 extends from the connection point P1F in the direction between the downstream direction of the first flow path P1 and the direction perpendicular to the first flow path P1.
  • the flushing portion 715 includes a flushing joint portion 715b that forms a portion connected to the second flow path P2 and the first flow path P1.
  • the flushing joint portion 715b is formed by the joint part 710A.
  • the flushing portion 715 forms the flushing port 715a.
  • the flushing portion 715 includes a flushing seat portion 715c to which the flushing valve unit 720 is coupled around the flushing port 715a.
  • the unit coupling portion 721b and the flushing seat portion 715c can be coupled to each other.
  • the backflow prevention part 750 may be disposed in the flushing port 715a.
  • the flushing portion 715 further includes an extension pipe 715d made of a flexible material.
  • the flushing portion 715 includes a flushing joint portion 715b that forms a part of the second flow path P2 extending in the direction between the downstream direction of the first flow path P1 and the vertical direction of the first flow path P1, .
  • the extension pipe 715d connects the flushing joint portion 715b and the flushing port 715a.
  • the extension pipe 715d forms a part of the second flow path P2.
  • the flushing liquid flows into the first flow path P1 sequentially from the outside through the flushing port 715a, the extension pipe 715d and the flushing joint portion 715b. It is possible to freely flex the extension pipe 715d according to the posture when the user injects the flushing liquid, which is convenient.
  • the flushing apparatus 700 '' according to the third embodiment includes a flushing unit 715 forming a second flow path P2 perpendicular to the first flow path P1.
  • the second flow path P2 can extend from the connection point P1F in the vertical direction of the first flow path P1.
  • the backflow prevention part 750 is disposed at the connection point P1F.
  • the protrusion 751 of the backflow prevention portion 750 protrudes into the first flow path P1 from the second flow path P2.
  • the hole 751h of the protrusion 751 is disposed in the first flow path P1.
  • the backflow prevention part 750 is disposed at the downstream end of the second flow path P2. There is no downstream portion with respect to the backflow prevention portion 750 of the second flow path P2.
  • the priming liquid flowing into the first flow path P1 from the connection pipe 300 or 300 'in the priming step fills the first flow path P1
  • bubbles in the second flow path P2 are separately removed It is convenient for the medical staff because the operation within the priming step is unnecessary. This is because there is no downstream portion of the second flow path P2 on the basis of the backflow prevention portion 750 and the airflow in the upstream portion of the second flow path P2 with respect to the backflow prevention portion 750, The air does not flow into the first flow path P1.
  • the flushing apparatus 700 '' 'according to the fourth embodiment includes a flushing unit 715' '' configured to be able to engage with the flushing port opening / closing unit 740 without engaging with the flushing valve unit 720.
  • the flushing port opening / closing part 740 according to the fourth embodiment need not have a function of disinfecting the surface 722a.
  • the flushing portion 715 '' ' may include a flushing engagement portion 715g' '' coupled to the joint portion 710A.
  • a flushing port 715a is formed at the upstream end of the opening / closing part 715h '' 'with reference to the direction of the flow of the flushing liquid.
  • the backflow prevention portion 750 is disposed at the downstream end of the flushing portion 715.
  • the flushing port opening / closing part 740 is coupled to or separated from the flushing part 715 to open / close the flushing port 715a.
  • the flushing apparatus 700 '' '' according to the fifth embodiment further includes a flushing vent cap 730 detachably coupled to the flushing unit 715.
  • the flushing valve unit 720 may be configured to be coupled to the flushing portion 715 to be replaceable with the flushing vent cap 730.
  • the flushing vent cap 730 is coupled to the flushing portion 715 before the start of the priming step.
  • the flushing vent cap 730 is coupled to the flushing part 715 in a state where the flushing valve unit 720 and the backflow prevention part 750 are not coupled to the flushing part 715.
  • the flushing vent cap 730 may be separated from the flushing portion 715 and the flushing valve unit 720 may be coupled to the flushing portion 715.
  • the flushing vent cap 730 When the priming liquid flows in the direction of the flushing port in the second flow path P2, the flushing vent cap 730 discharges the gas and blocks the discharge of the priming liquid.
  • the flushing vent cap 730 includes a vent filter 731 that blocks the passage of the priming liquid and allows passage of gas.
  • the vent filter 731 may comprise a hydrophobic filter.
  • the downstream vent cap 780 may include a sponge 732 disposed upstream of the vent filter 731.
  • the downstream end of the sponge 732 is in contact with the vent filter 731.
  • Sponge 732 assists passage of gas while absorbing the priming liquid.
  • the downstream vent cap 780 includes a flushing vent casing 733 for receiving a vent filter 731 therein.
  • the flushing vent casing 733 receives the sponge 732 therein.
  • the flushing vent casing 733 forms a vent hole 733a through which the gas passes.
  • the vent hole 733a is disposed on the downstream side of the vent filter 731. [ The gas in the second flow path P2 sequentially flows out of the second flow path P2 via the sponge 732, the vent filter 731 and the vent hole 733a.
  • the downstream vent cap 780 also includes a flushing vent cap engagement portion 734 coupled with the flushing portion 715.
  • the flushing vent cap engaging portion 734 may be formed in a cylindrical shape.
  • the flushing vent cap coupling portion 734 is connected to the downstream side of the flushing vent casing 733 based on the direction of the inflow flow of the flushing liquid.
  • a screw (not shown) may be formed in the flushing vent cap engaging portion 734.
  • the screw of the flushing cap cap 730 is formed to engage with the corresponding portion of the flushing portion 715.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A flushing apparatus according to embodiments of the present disclosure comprises: a main body which is configured to connect a connection pipe for guiding hazardous medical liquid, harmful to a human body when exposed to external air, to a patient connection module for injecting the hazardous medical liquid to a patient, has a first flow channel formed to guide the hazardous medical liquid from the connection pipe to the patient connection module, and includes a flushing portion having a second flow channel formed to be connected to a predetermined connection point located between both ends of the first flow channel; and a flow rate reduction portion which is arranged upstream of the connection point in the first flow channel, and is configured to reduce the flow rate of the hazardous medical liquid flowing in the first flow channel. The present disclosure presents various embodiments of such a flushing apparatus.

Description

위험 약액 주입용 플러싱 장치 및 위험 약액 주입 장치Flushing device for injecting dangerous chemicals and injecting device for dangerous chemicals

본 개시는 위험 약액의 주입을 위한 의료용 장치에 관한 것이다.The present disclosure relates to a medical device for the injection of dangerous chemical liquids.

환자에게 약물을 공급하기 위해, 환자에게 액상의 약물을 주입하는 약액 주입 장치가 알려져 있다. 상기 약액 주입 장치를 이용하여, 소정의 저장 공간 내에 있는 약액이 환자와 연결되는 통로(예를 들어, 관 및 주사 바늘의 내부 공간)를 통과하여, 환자의 체내로 유입된다.In order to supply a drug to a patient, a drug solution injecting device for injecting a liquid drug into the patient is known. The drug solution in the predetermined storage space is introduced into the patient's body through the passage (for example, the inner space of the tube and the injection needle) that is connected to the patient by using the above-described drug solution injector.

한편, 외부의 공기 중에 노출 시 인체에 유해한 영향을 미치는 위험 약물이 알려져 있다. 예를 들어, 상기 위험 약물로 5-FU 등의 항암제를 들 수 있다. 상기 약액 주입 장치를 이용하여 '액상의 상기 위험 약물'(이하, '위험 약액'이라 지칭함)을 환자에게 주입할 때, 상기 위험 약액이 약액 주입 장치의 외부의 공기로 노출될 경우, 인체의 피부에 묻거나 기화되어 인체의 호흡기로 유입되는 등으로 인해서 환자 및 의료진(의사, 간호사 등)에게 치명적인 위해를 가할 수 있다.On the other hand, dangerous drugs are known which have harmful effects on the human body when exposed to the outside air. For example, the above-mentioned dangerous drugs include anticancer agents such as 5-FU. When the dangerous chemical liquid is exposed to the outside air of the chemical liquid injecting apparatus when injecting the 'dangerous chemical liquid' (hereinafter referred to as 'dangerous chemical liquid') into the patient by using the chemical liquid injecting apparatus, (Such as doctors, nurses, etc.) due to the fact that they are burnt or vaporized into the respiratory system of the human body.

한편, 의료 목적 상, 환자의 체내로 일시에 위험 약액이 주입되는 것을 방지하고 상당 시간 동안 서서히 체내로 위험 약물이 주입되도록 구성된 유속 조절 모듈이 알려져 있다. 상기 유속 조절 모듈은, 상기 약액 주입 장치의 상기 통로에 배치되어 통로 내에서 흐르는 액체의 유속을 저감시킨다.On the other hand, for medical purposes, a flow rate control module is known in which a dangerous drug is injected into the body of a patient at a time and slowly injected into the body for a considerable period of time. The flow rate adjusting module is disposed in the passage of the chemical liquid injecting device to reduce the flow rate of the liquid flowing in the passage.

한편, 상기 약액 주입 장치를 이용하는 과정에서 환자의 체내로 공기가 유입되는 것을 막기 위해, 환자에게 주사 바늘을 연결하기 전 상태에서 환자와 연결될 통로(예를 들어, 관 및 주사 바늘의 내부 공간)에 액체(예를 들어, 주입하고자 하는 약액)를 채우는 프라이밍(priming) 작업이 알려져 있다.On the other hand, in order to prevent air from being introduced into the patient's body during the use of the liquid medicament injecting device, a pathway (for example, an inner space of the tube and the injection needle) A priming operation for filling a liquid (for example, a chemical solution to be injected) is known.

만약 상기 위험 약액을 환자에게 주입하기 전의 상기 프라이밍 작업 시 상기 통로를 상기 위험 약액으로 채우게 된다면, 주사 바늘 끝 부분 등에서 상기 위험 약액이 외부 공기로 노출되는 위험이 있다. 이에 따라, 종래에는, 상기 위험 약액 주입 전 프라이밍 작업 시 인체에 무해한 프라이밍용 액체를 상기 통로에 채우는 방법이 알려져 있다.If the passage is filled with the dangerous chemical liquid during the priming operation before injecting the dangerous chemical liquid into the patient, there is a risk that the dangerous chemical liquid is exposed to the outside air at the injection needle tip or the like. Accordingly, in the prior art, there has been known a method of filling a priming liquid which is harmless to the human body in priming operation before injection of the dangerous chemical liquid into the passage.

종래의 약액 주입 장치에는, 상기 프라이밍용 액체를 상기 통로 내로 유입시키기 위한 소정의 유입구가 구성된다. 상기 프라이밍 작업 시 상기 통로 내부를 전체적으로 상기 프라이밍용 액체로 채우기 위해서, 상기 유입구는 상기 통로의 상류 측 부분에 배치된다. 이에 따라, 종래의 약액 주입 장치에서, 상기 유속 저감 모듈은 상기 유입구의 하류 측에 배치된다.In the conventional chemical liquid injecting apparatus, a predetermined inlet for introducing the priming liquid into the passage is constituted. In order to fill the inside of the passageway with the priming liquid as a whole during the priming operation, the inlet is disposed at an upstream portion of the passageway. Accordingly, in the conventional chemical liquid injecting apparatus, the flow rate reduction module is disposed on the downstream side of the inlet.

본 개시는 의료진이 상기 위험 약물을 이용한 의료 행위를 안전하고 편리하게 수행할 수 있도록 도울 수 있다.This disclosure may help a medical practitioner to safely and conveniently perform a medical treatment using the dangerous drug.

종래 기술에서는, 환자에게 상기 위험 약물의 주입이 완료된 후 주사 바늘을 환자로부터 분리할 때에, 주사 바늘의 끝으로부터 상기 위험 약물이 유출됨으로써 인체에 치명적인 위해를 가할 수 있는 문제가 여전히 존재한다. 본 개시는 이러한 문제를 해결하기 위한 후술할 플러싱(flushing) 단계를 용이하게 수행할 수 있도록 도울 수 있다.There is still a problem in that when the injection needle is separated from the patient after the injection of the dangerous drug is completed in the patient, the dangerous drug is leaked from the end of the injection needle, thereby lethally damaging the human body. The present disclosure can help to facilitate the flushing step described below to solve this problem.

종래 기술에서, 상기 플러싱 단계를 수행하기 위해 상기 프라이밍용 액체의 유입을 위한 상기 유입구를 통해 후술할 플러싱용 액체를 상기 통로 내로 유입하면, 상기 유입구의 하류 측에 배치된 상기 유속 저감 모듈에 의해서 상기 플러싱 단계의 소요 시간이 길어지는 문제가 있다. 특히, 위험 약액 주입의 부작용 등 갑작스러운 의료상 필요에 의해, 위험 약액의 주입 도중에 위험 약액의 주입을 중지하고 상기 플러싱 단계를 수행하고자 할 때, 상기 유입구를 통해 상기 플러싱용 액체를 유입시킨다면, 의료 행위의 큰 지연이 발생하여 환자에게 돌이킬 수 없는 피해를 입힐 수 있는 문제가 있을 뿐만 아니라, 상기 유입구를 기준으로 상기 통로 내의 하류 측에 잔류한 상당량의 위험 약액을 환자에게 불필요하게 마저 주입하게 되는 문제가 있다. 본 개시는 이러한 문제를 해결하여, 상기 플러싱 단계가 시작된 이후 빠른 시간 내에 상기 플러싱 단계를 마칠 수 있게 도와주고, 불필요하게 환자에게 추가 주입되는 상기 위험 약액의 양을 줄일 수 있다.In the prior art, when the flushing liquid, which will be described later, is introduced into the passage through the inlet for introducing the priming liquid to perform the flushing step, the flow rate reduction module disposed on the downstream side of the inlet There is a problem that the time required for the flushing step becomes long. Particularly, when the injection of the dangerous chemical liquid is stopped during the injection of the dangerous chemical liquid and the flushing step is performed due to a sudden medical need such as a side effect of injecting the dangerous chemical liquid, if the flushing liquid is introduced through the inlet, There is a problem that a large delay of the action occurs and irreversible damage is caused to the patient as well as a problem that a considerable amount of the dangerous chemical solution remaining on the downstream side in the passage based on the inlet is unnecessarily injected into the patient . The present disclosure solves this problem, helps to complete the flushing step within a short period of time after the flushing step is started, and can reduce the amount of the dangerous chemical solution unnecessarily injected into the patient.

본 개시는 상기 과제들을 해결하면서도, 상기 프라이밍 작업도 안전하고 편리하게 수행될 수 있도록 도울 수 있다.While the present invention solves the above problems, the present disclosure can help the priming operation to be performed safely and conveniently.

환자에게 위험 약액 주입을 마친 후 상기 약액 주입 장치의 내부에는 위험 약액이 잔류한다. 종래 기술에서, 위험 약액 주입용으로 사용 완료한 상기 약액 주입 장치를 폐기 처분하는 과정에서, 상기 약액 주입 장치 내부의 잔류 위험 약액이 외부로 누출될 위험이 있다. 본 개시는 이러한 사용 후의 약액 주입 장치로부터 위험 약액의 누출 위험성을 줄일 수 있다.After the injection of the hazardous chemical liquid into the patient is completed, the dangerous chemical liquid remains in the chemical liquid injecting apparatus. In the prior art, there is a risk that the residual dangerous chemical liquid in the chemical liquid injecting apparatus leaks to the outside in the process of discarding the chemical liquid injecting apparatus that has been used for injecting the dangerous chemical liquid. This disclosure can reduce the risk of leakage of the dangerous chemical liquid from the chemical liquid injecting apparatus after such use.

본 개시의 실시예에 따른 위험 약액 주입용 플러싱 장치는, 외부 공기에 노출 시 인체에 유해한 위험 약액을 안내하기 위한 연결 관과 상기 위험 약액을 환자에게 주입하기 위한 환자 연결 모듈을 연결하도록 구성되고, 상기 연결 관으로부터 상기 환자 연결 모듈로 상기 위험 약액을 안내하는 제1 유로를 형성하고, 상기 제1 유로의 양단 사이에 위치하는 소정의 연결 지점에 연결되는 제2 유로를 형성하는 플러싱부를 구비하는 메인 바디; 및 상기 제1 유로에서 상기 연결 지점보다 상류 측에 배치되고, 상기 제1 유로 내에 흐르는 상기 위험 약액의 유속을 저감하도록 구성되는 유속 저감부를 포함한다.The flushing apparatus for injecting a hazardous chemical solution according to an embodiment of the present disclosure is configured to connect a connection pipe for guiding a hazardous chemical liquid harmful to a human body when exposed to outside air and a patient connection module for injecting the dangerous chemical liquid into a patient, And a flushing portion for forming a first flow path for guiding the hazardous liquid from the connection tube to the patient connection module and a second flow path connected to a predetermined connection point located between both ends of the first flow path, body; And a flow rate reduction unit arranged on the upstream side of the connection point in the first flow path and configured to reduce a flow rate of the hazardous liquid flowing in the first flow path.

본 개시의 실시예에 따른 위험 약액 주입 장치는, 상기 위험 약액을 가압하도록 구성된 펌핑 모듈; 상기 펌핑 모듈에서의 가압에 따라 상기 펌핑 모듈로부터 유출되는 상기 위험 약액이 흐르는 연결 관; 및 상기 플러싱 장치를 포함한다.The apparatus for injecting a dangerous chemical liquid according to an embodiment of the present disclosure includes: a pumping module configured to pressurize the dangerous chemical liquid; A connection pipe through which the dangerous chemical liquid flowing out from the pumping module flows according to the pressure in the pumping module; And a flushing device.

실시예에 따르면, 상기 메인 바디는 일체로 형성된 조인트 파트를 포함할 수 있다. 상기 조인트 파트는, 상기 유속 저감부의 하류 측 말단으로부터 상기 연결 지점까지 연결하는, 상기 제1 유로의 일 부분인 연결 유로를 형성할 수 있다.According to an embodiment, the main body may include an integrally formed joint part. The joint part may form a connection flow path that is a part of the first flow path connecting the downstream end of the flow rate reduction part to the connection point.

상기 플러싱 장치를 통해서, 의료진과 환자에게 안전하게 상기 위험 약물을 다룰 수 있게 도와주고, 의료진의 위험 약물을 주입하는 의료 행위의 편리성을 향상시킬 수 있다.Through the flushing device, it is possible to safely handle the dangerous drug to the medical staff and the patient, and to improve the convenience of the medical treatment for injecting the dangerous medicine of the medical staff.

또한, 상기 플러싱 장치를 통해서, 상기 유속 저감부의 기능을 편리하게 이용하면서도, 긴급하게 환자로부터 환자 연결 모듈을 분리하는 상황에서, 상기 플러싱 작업의 소요 시간을 짧게 해 주고, 환자에게 불필요하게 주입되는 상기 위험 약액의 양을 줄일 수 있다.Further, it is possible to shorten the time required for the flushing operation in a situation where the patient connecting module is separated from the patient urgently while conveniently using the function of the flow rate reduction unit through the flushing apparatus, The amount of dangerous chemicals can be reduced.

또한, 상기 조인트 파트를 구비함으로써, 상기 플러싱 작업 이후 상기 플러싱 장치를 폐기 처분할 때, 상기 조인트 파트가 분리되어 내부의 상기 위험 약액이 외부로 노출되는 위험 상황의 발생 확률을 줄일 수 있다. Further, by providing the joint part, when the flushing apparatus is discarded after the flushing operation, the probability of occurrence of a dangerous situation in which the joint part is separated and the internal dangerous chemical liquid is exposed to the outside can be reduced.

또한, 상기 조인트 파트는 분리 및 조립 과정이 불필요하므로, 비위생적인 이물질이나 바이러스 등의 감염 물질이 유로 내로 유입될 확률을 현저히 감소시킬 수 있다.Further, since the joint part does not need to be separated and assembled, it is possible to significantly reduce the probability that infectious substances such as unhygienic foreign substances and viruses are introduced into the flow path.

도 1a는 본 개시의 일 실시예에 따른 위험 약액 주입 장치(1)의 전체 시스템을 보여주는 개념도이다.1A is a conceptual diagram showing an entire system of a dangerous chemical liquid injector 1 according to an embodiment of the present disclosure.

도 1b는 본 개시의 다른 일 실시예에 따른 위험 약액 주입 장치(1')의 전체 시스템을 보여주는 개념도이다.1B is a conceptual diagram showing an entire system of a dangerous chemical liquid injector 1 'according to another embodiment of the present disclosure.

도 2는, 도 1a 및 도 1b의 위험 약액 주입 장치(1, 1')의 제1 실시예에 따른 플러싱 장치(700)의 입면도이다.2 is an elevational view of the flushing apparatus 700 according to the first embodiment of the apparatus for injecting hazardous chemical liquids 1, 1 'of Figs. 1A and 1B.

도 3은, 도 2에서 플러싱 포트 개폐부(740)를 제외한 상태의 플러싱 장치(700)를 유로(P)를 따라 자른 단면도이다. 도 3에는, 부분적인 작동 메커니즘을 보여주는 부분 확대도가 도시된다.3 is a cross-sectional view of the flushing apparatus 700 except for the flushing port opening / closing part 740 cut along the flow path P in FIG. Figure 3 shows a partial enlarged view showing a partial operating mechanism.

도 4는, 도 3에서 하류 벤트 캡(780)을 제외한 상태의 플러싱 장치(700)의 분해 사시도이다.4 is an exploded perspective view of the flushing apparatus 700 in a state where the downstream vent cap 780 is removed in FIG.

도 5는, 도 1a 및 도 1b의 위험 약액 주입 장치(1, 1')의 제2 실시예에 따른 플러싱 장치(700')의 입면도이다.5 is an elevational view of a flushing apparatus 700 'according to a second embodiment of the apparatus for injecting hazardous chemical liquids 1, 1' of Figs. 1A and 1B.

도 6은, 도 5의 플러싱 장치(700')의 분해 사시도이다.6 is an exploded perspective view of the flushing apparatus 700 'of FIG.

도 7은, 도 1a 및 도 1b의 위험 약액 주입 장치(1, 1')의 제3 실시예에 따른 플러싱 장치(700'')의 입면도이다.7 is an elevational view of a flushing device 700 '' according to a third embodiment of the hazardous liquid injection device 1, 1 'of Figs. 1A and 1B.

도 8은, 도 7의 플러싱 장치(700'')를 유로(P)를 따라 자른 단면도이다.Fig. 8 is a cross-sectional view of the flushing apparatus 700 "of Fig. 7 taken along the flow path P. Fig.

도 9는, 도 8의 플러싱 장치(700'')의 분해 사시도이다.Fig. 9 is an exploded perspective view of the flushing device 700 '' of Fig.

도 10은, 도 1a 및 도 1b의 위험 약액 주입 장치(1, 1')의 제4 실시예에 따른 플러싱 장치(700''')를 유로(P)를 따라 자른 단면도이다.10 is a cross-sectional view of a flushing apparatus 700 '' 'according to a fourth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1' shown in FIGS. 1A and 1B along a flow path P. FIG.

도 11은, 도 1a 및 도 1b의 위험 약액 주입 장치(1, 1')의 제5 실시예에 따른 플러싱 장치(700'''')를 유로(P)를 따라 자른 단면도이다.11 is a cross-sectional view of a flushing apparatus 700 '' '' according to a fifth embodiment of the apparatus for injecting dangerous chemical liquids 1 and 1 'shown in FIGS. 1A and 1B along a flow path P. FIG.

본 개시의 실시예들은 본 개시의 기술적 사상을 설명하기 위한 목적으로 예시된 것이다. 본 개시에 따른 권리범위가 이하에 제시되는 실시예들이나 이들 실시예들에 대한 구체적 설명으로 한정되는 것은 아니다.The embodiments of the present disclosure are illustrated for the purpose of describing the technical idea of the present disclosure. The scope of the claims according to the present disclosure is not limited to the embodiments described below or to the detailed description of these embodiments.

본 개시에 사용되는 모든 기술적 용어들 및 과학적 용어들은, 달리 정의되지 않는 한, 본 개시가 속하는 기술 분야에서 통상의 지식을 가진 자에게 일반적으로 이해되는 의미를 갖는다. 본 개시에 사용되는 모든 용어들은 본 개시를 더욱 명확히 설명하기 위한 목적으로 선택된 것이며 본 개시에 따른 권리범위를 제한하기 위해 선택된 것이 아니다.All technical and scientific terms used in the present disclosure have the meaning commonly understood by one of ordinary skill in the art to which this disclosure belongs unless otherwise defined. All terms used in the disclosure are selected for the purpose of more clearly illustrating the disclosure and are not chosen to limit the scope of the rights under the present disclosure.

본 개시에서 사용되는 "포함하는", "구비하는", "갖는" 등과 같은 표현은, 해당 표현이 포함되는 어구 또는 문장에서 달리 언급되지 않는 한, 다른 실시예를 포함할 가능성을 내포하는 개방형 용어(open-ended terms)로 이해되어야 한다.As used in this disclosure, expressions such as " comprising, " " having, " " having, " and the like, unless the context requires otherwise, (open-ended terms).

본 개시에서 기술된 단수형의 표현은 달리 언급하지 않는 한 복수형의 의미를 포함할 수 있으며, 이는 청구범위에 기재된 단수형의 표현에도 마찬가지로 적용된다.The expressions of the singular forms described in this disclosure may include plural meanings unless the context clearly dictates otherwise, and the same applies to the singular expressions set forth in the claims.

본 개시에서 사용되는 "제1", "제2" 등의 표현들은 복수의 구성요소들을 상호 구분하기 위해 사용되며, 해당 구성요소들의 순서, 중요도, 또는 주종관계를 한정하는 것은 아니다. As used in this disclosure, expressions such as " first ", " second ", and the like are used to distinguish a plurality of components from one another, and do not limit the order, importance, or generality of the components.

이하, 첨부한 도면들을 참조하여, 본 개시의 실시예들을 설명한다. 첨부된 도면에서, 서로 다른 실시예들을 구분하기 위하여, 도면 참조부호의 뒤에 프라임(prime) 기호(') 또는 복수의 프라임 기호('', ''', '''')를 표시할 수 있다. 또한, 첨부된 도면에서, 동일하거나 대응하는 구성요소에는 동일한 참조부호가 부여되어 있다. 또한, 이하의 실시예들의 설명에 있어서, 동일하거나 대응하는 구성요소를 중복하여 기술하는 것이 생략될 수 있다. 그러나, 구성요소에 관한 기술이 생략되어도, 그러한 구성요소가 어떤 실시예에 포함되지 않는 것으로 의도되지는 않는다.Hereinafter, embodiments of the present disclosure will be described with reference to the accompanying drawings. In the accompanying drawings, a prime symbol (') or a plurality of prime symbols (' ',' '', '' '') may be displayed after the reference numerals in order to distinguish between different embodiments . Also, in the accompanying drawings, the same or corresponding components are denoted by the same reference numerals. In the following description of the embodiments, description of the same or corresponding components may be omitted. However, even if a description of components is omitted, such components are not intended to be included in any embodiment.

본 개시에서 "위험 약액"이란, 외부 공기에 노출 시 인체에 유해한 약액을 의미한다. 상기 위험 약액은, 인체의 피부에 묻거나 기화되어 인체의 호흡기로 유입되면 인체에 악영향을 미친다고 알려진 약액이다. 예를 들어, 상기 위험 약액으로 5-FU 등의 함암제 액(液)을 들 수 있다.In the present disclosure, " dangerous chemical liquid " means a chemical liquid which is harmful to the human body when exposed to the outside air. The dangerous chemical liquid is a chemical liquid known to adversely affect the human body if it is adhered to the skin of the human body or is vaporized and flows into the respiratory system of the human body. For example, as the above-mentioned dangerous chemical solution, there can be mentioned an immobilized liquid such as 5-FU.

이하, 도 1a 및 도 1b를 참고하여, 본 개시의 일 실시예 및 다른 일 실시예에 따른 위험 약액 주입 장치(1, 1')를 설명하면 다음과 같다. 위험 약액 주입 장치(1, 1')는 상기 위험 약액을 가압하도록 구성된 펌핑 모듈(100)을 포함한다. 위험 약액 주입 장치(1, 1')는 상기 위험 약액을 안내하기 위한 연결 관(300, 300')을 포함한다. 펌핑 모듈(100)에서의 가압에 따라 펌핑 모듈(100)로부터 유출되는 상기 위험 약액이 연결 관(300, 300')을 통해 흐른다.Hereinafter, with reference to FIGS. 1A and 1B, an apparatus for injecting a dangerous chemical solution 1, 1 'according to an embodiment of the present disclosure and another embodiment will be described. The apparatus for injecting a dangerous chemical solution (1, 1 ') comprises a pumping module (100) configured to pressurize the dangerous chemical liquid. The apparatus for injecting a dangerous chemical solution (1, 1 ') comprises a connecting pipe (300, 300') for guiding the dangerous chemical liquid. According to the pressure in the pumping module 100, the dangerous chemical liquid flowing out from the pumping module 100 flows through the connection pipes 300 and 300 '.

위험 약액 주입 장치(1, 1')는, 연결 관(300, 300') 또는 펌핑 모듈(100)에 연결되는 포트 모듈(200, 200')을 포함할 수 있다. 포트 모듈(200, 200')은, 펌핑 모듈(100) 내로 액체(예를 들어, 위험 약물 또는 프라이밍용 액체)를 충전 가능하도록 구성된다. 포트 모듈(200, 200')을 통해 유입된 상기 액체는 펌핑 모듈(100) 내로 유입될 수 있다.The apparatus for injecting a dangerous chemical solution 1 or 1 'may include a port module 200 or 200' connected to the connection pipe 300 or 300 'or the pumping module 100. The port modules 200 and 200 'are configured to be capable of filling liquid (e.g., dangerous drug or priming liquid) into the pumping module 100. The liquid introduced through the port modules 200, 200 'may be introduced into the pumping module 100.

상기 프라이밍용 액체란, 외부 공기에 노출되어도 인체에 무해하고 체내에 유입되어도 무방한 액체를 의미한다. 예를 들어, 상기 프라이밍용 액체로 식염수(saline solution)를 들 수 있다.The priming liquid means a liquid that is harmless to the human body even when exposed to the outside air, and can flow into the body. For example, the liquid for priming may be a saline solution.

위험 약액 주입 장치(1, 1')는 연결 관(300, 300')의 적어도 어느 한 지점의 개폐 여부를 변경하도록 구성된 연결관 개폐 모듈(400, 400')을 포함할 수 있다. 위험 약액 주입 장치(1, 1')는 연결 관(300, 300') 내로 흐르는 액체의 이물질을 걸러내는 필터 모듈(500)을 포함할 수 있다.The dangerous chemical liquid injector 1 or 1 'may include a connection pipe opening / closing module 400 or 400' configured to change whether at least one of the connection pipes 300 and 300 'is open or closed. The apparatus for injecting hazardous chemical liquids 1 and 1 'may include a filter module 500 for filtering out foreign substances of liquid flowing into the connection pipes 300 and 300'.

위험 약액 주입 장치(1, 1')는 상기 위험 약액을 환자에게 주입하기 위한 환자 연결 모듈(600, 600')을 포함한다. 환자 연결 모듈(600, 600')은 주사 바늘(610) 등 환자의 체내로 인입되는 구성 요소를 포함한다.The apparatus for injecting a dangerous chemical solution (1, 1 ') includes a patient connection module (600, 600') for injecting the dangerous chemical into the patient. The patient connection module 600, 600 'includes components that are introduced into the patient's body, such as the injection needle 610.

환자 연결 모듈(600, 600')은, '주사 바늘(610) 등 환자의 체내로 인입되는 구성 요소를 포함하는 인입 부품'과 '나머지 부품'을 포함할 수 있다. 상기 인입 부품과 상기 나머지 부품은 서로 분리 가능하게 결합될 수 있다. 이 경우, 상기 인입 부품은 환자와 연결되어 있되 상기 나머지 부품과 분리된 상태에서, 사용자는 상기 나머지 부품을 플러싱 장치(700, 700', 700'', 700''', 700'''')와 결합시킨 후, 상기 인입 부품과 상기 나머지 부품을 서로 결합시킬 수 있다. 이 경우, 플러싱 장치(700, 700', 700'', 700''', 700'''')를 거친 액체는 순차적으로 상기 나머지 부품과 상기 인입 부품을 거쳐, 환자의 체내로 유입될 수 있다.The patient connection module 600, 600 'may include an inlet part including a component to be introduced into the patient's body, such as the injection needle 610, and a remainder part. The lead-in part and the remaining part may be detachably coupled to each other. In this case, the inflow part is connected to the patient but is separated from the remaining part, and the user inserts the remaining part into the flushing device 700, 700 ', 700' ', 700' '', 700 " And then joining the lead-in part and the remaining part to each other. In this case, the liquid passing through the flushing devices 700, 700 ', 700' ', 700' '', 700 '' '' may be sequentially introduced into the patient's body via the remaining part and the incoming part .

위험 약액 주입 장치(1, 1')는 연결 관(300, 300')과 환자 연결 모듈(600, 600')을 연결하도록 구성된 플러싱 장치(700, 700', 700'', 700''', 700'''')를 포함한다. 플러싱 장치(700, 700', 700'', 700''', 700'''')는 연결 관(300, 300')으로부터 환자 연결 모듈(600, 600')로 상기 위험 약액을 안내하는 제1 유로(P1)를 형성한다. 플러싱 장치(700, 700', 700'', 700''', 700'''')는 제1 유로(P1)의 양단 사이에 위치하는 소정의 연결 지점(P1F)에 연결되는 제2 유로(P2)를 형성한다. 외부로부터 제2 유로(P2)를 통해 제1 유로(P1) 내로 플러싱용 액체를 유입시킬 수 있다.The apparatus for injecting a dangerous chemical solution 1, 1 'comprises a flushing device 700, 700', 700 ", 700 '' ', 700' ', 700 " " '). The flushing devices 700, 700 ', 700' ', 700' '', 700 '' '' are connected to the patient connection modules 600 and 600 ' Thereby forming one flow path P1. The flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a second flow path (not shown) connected to a predetermined connection point P1F located between both ends of the first flow path P1 P2. The liquid for flushing can flow into the first flow path P1 from the outside through the second flow path P2.

상기 플러싱용 액체란, 외부 공기에 노출되어도 인체에 무해하고 체내에 유입되어도 무방한 액체를 의미한다. 예를 들어, 상기 플러싱용 액체로 식염수(saline solution)를 들 수 있다.The flushing liquid means a liquid that is harmless to the human body even when it is exposed to the outside air and can flow into the body. For example, the liquid for flushing may be a saline solution.

본 개시의 실시예들에 따른 위험 약액 주입 장치(1, 1')를 이용하여 상기 위험 약액을 환자에게 주입하는 과정은, 순차적으로 진행되는 프라이밍(Priming) 단계, 약액 주입 단계 및 플러싱(Flushing) 단계를 포함한다.The process of injecting the dangerous chemical liquid into the patient using the dangerous chemical liquid injector 1 or 1 'according to the embodiments of the present disclosure may include a priming process, a chemical liquid injection process, and a flushing process, .

'환자 연결 모듈(600, 600')이 환자로부터 분리된 상태' 또는 '환자 연결 모듈(600, 600')의 상기 인입 부품이 환자와 연결되어 있되 상기 나머지 부품이 분리된 상태'에서, 상기 프라이밍 단계가 진행된다. 상기 프라이밍 단계에서, 상기 위험 약액이 흘러가도록 기설정된 소정의 통로 내에 프라이밍용 액체가 채워진다. 상기 프라이밍 단계를 수행한 후, 환자에게 환자 연결 모듈(600, 600')을 연결하거나 상기 인입 부품을 상기 나머지 부품에 결합함으로써, 상기 프라이밍 단계에서 상기 위험 약액의 외부 공기로의 노출을 막을 수 있다.In the state where the patient connection module 600 or 600 'is disconnected from the patient' or the 'incoming connection part of the patient connection module 600 or 600' is connected to the patient but the remaining part is disconnected, The step proceeds. In the priming step, priming liquid is filled in predetermined predetermined passageways through which the dangerous chemical liquid flows. After performing the priming step, exposure of the dangerous chemical liquid to the outside air can be prevented in the priming step by connecting the patient connection module 600, 600 'to the patient or coupling the lead-in part to the remaining part .

본 실시예에서, 상기 소정의 통로는 연결 관(300, 300') 및 플러싱 장치(700, 700', 700'', 700''', 700'''')를 포함한다. 상기 소정의 통로는 플러싱 장치(700, 700', 700'', 700''', 700'''')에 연결되는 환자 연결 모듈(600, 600')을 더 포함할 수 있다.In the present embodiment, the predetermined passage includes a connection pipe 300 and 300 'and a flushing device 700, 700', 700 '', 700 '' ', and 700' '' '. The predetermined passage may further include a patient connection module 600, 600 'connected to the flushing device 700, 700', 700 '', 700 '' ', 700' '' '.

환자에게 환자 연결 모듈(600, 600')을 연결한 후, 상기 약액 주입 단계가 진행된다. 상기 약액 주입 단계에서, 펌핑 모듈(100)에서의 가압에 따라 상기 위험 약액이 상기 소정의 통로를 따라 흐른다. 이에 따라, 상기 약액 주입 단계의 초반에는 상기 소정의 통로 내에 채워져 있던 상기 프라이밍용 액체가 환자의 체내로 유입된다. 그 후, 상기 프라이밍용 액체의 뒤를 이어 흘러가는 상기 위험 약액이 환자의 체내로 유입되기 시작한다.After connecting the patient connection module 600, 600 'to the patient, the chemical liquid injection step is performed. In the chemical liquid injection step, the dangerous chemical liquid flows along the predetermined passage in accordance with the pressure in the pumping module 100. Accordingly, in the early stage of the chemical liquid injecting step, the priming liquid filled in the predetermined passage flows into the patient's body. Thereafter, the dangerous chemical liquid flowing after the priming liquid starts to flow into the patient's body.

상기 약액 주입 단계 후, 상기 플러싱 단계가 진행된다. 상기 플러싱 단계에서, 플러싱 장치(700, 700', 700'', 700''', 700'''')를 통해 플러싱용 액체가 상기 소정의 통로 내의 소정의 중간 지점으로 유입된다. 상기 플러싱 단계에서, 유입된 플러싱용 액체는, 상기 소정의 통로 내의 하류 측 부분에 채워진 상기 위험 약물을 하류 방향으로 밀어낸다. 이에 따라, 상기 플러싱 단계의 초반에는, 상기 소정의 통로의 하류 측 부분 내에 채워져 있던 상기 위험 약물이 환자의 체내로 유입된다. 그 후, 상기 위험 약물의 뒤를 이어 흘러가는 상기 플러싱용 액체가 환자의 체내로 유입되기 시작한다. 환자의 체내로 상기 플러싱용 액체가 유입되기 시작한 후, 환자로부터 환자 연결 모듈(600, 600')을 분리시킴으로써 상기 플러싱 단계를 종료할 수 있으며, 상기 위험 약액의 외부 공기로 노출 없이 위험 약물의 주입 과정을 마칠 수 있다.After the chemical liquid injecting step, the flushing step proceeds. In the flushing step, liquid for flushing flows into a predetermined intermediate point in the predetermined passage through the flushing apparatuses 700, 700 ', 700' ', 700' '', and 700 '' ''. In the flushing step, the introduced flushing liquid pushes the dangerous drug filled in the downstream portion in the predetermined passage in the downstream direction. Accordingly, in the early stage of the flushing step, the dangerous drug, which has been filled in the downstream side portion of the predetermined passage, flows into the patient's body. Thereafter, the flushing liquid flowing after the dangerous drug starts to flow into the patient's body. The flushing step may be terminated by separating the patient connection module 600 or 600 'from the patient after the flushing liquid starts to flow into the patient's body, and the injection of the dangerous drug You can complete the process.

본 개시에서 사용되는 "상류" 및 "하류"는, 펌핑 모듈(100)이 위험 약액을 가압할 때 연결 관(300, 300'), 유로(P) 및 환자 연결 모듈(600, 600') 내에서 상기 위험 약액이 흐르는 방향을 기준으로 정의된다. 구체적으로, 도 1a 및 도 1b의 화살표 F2, F3 및 F4의 화살표 방향이 하류 방향으로 정의되고, 상기 하류 방향의 반대 방향이 상류 방향으로 정의된다.The "upstream" and "downstream" used in the present disclosure mean that the pumping module 100 is in fluid communication with the connection pipe 300, 300 ', the flow path P and the patient connection module 600, 600' Is defined based on a direction in which the dangerous chemical flows. Specifically, arrow directions of arrows F2, F3 and F4 in Figs. 1A and 1B are defined as the downstream direction, and the direction opposite to the downstream direction is defined as the upstream direction.

도 1a 및 도 1b를 참고하여, 펌핑 모듈(100)은 상기 위험 약액을 수용 가능하도록 구성된 챔버(110)를 포함한다. 챔버(110)는 가압 유닛(120)과 함께 내부 공간을 형성한다. 상기 내부 공간에 상기 위험 약액이 저장될 수 있다. 다른 일 실시예에서는, 상기 내부 공간에 일시적으로 상기 프라이밍용 액체가 저장될 수 있다.Referring to FIGS. 1A and 1B, the pumping module 100 includes a chamber 110 configured to receive the hazardous chemical liquid. The chamber 110 forms an internal space with the pressurizing unit 120. And the dangerous chemical liquid may be stored in the internal space. In another embodiment, the priming liquid may be temporarily stored in the inner space.

챔버(110)에는, 챔버(110) 내부의 액체가 배출되는 배출 포트부(111)가 형성된다. 배출 포트부(111)는 챔버(110)의 외 표면에서 돌출될 수 있다.In the chamber 110, a discharge port portion 111 through which liquid in the chamber 110 is discharged is formed. The discharge port portion 111 may protrude from the outer surface of the chamber 110.

본 실시예에서, 배출 포트부(111)에 밸브(111a)가 배치될 수 있다. 밸브(111a)는 연결 관(300, 300')의 상류 측 말단에 배치되는 모듈 연결부(350)에 의해 눌릴 때, 배출 포트부(111)를 개방시키도록 구성될 수 있다. 밸브(111a)는 스웨버블 밸브(swab-able valve)(111a)를 포함할 수 있다. 상기 스웨버블 밸브(111a)는 외부로부터 누름 시 개방되는 홀을 형성하는 표면을 포함한다. 상기 스웨버블 밸브(111a)는, 사용자가 상기 스웨버블 밸브의 상기 표면을 닦을 수 있도록 구성된다.In this embodiment, the valve 111a may be disposed in the discharge port portion 111. [ The valve 111a may be configured to open the discharge port portion 111 when pressed by the module connection portion 350 disposed at the upstream end of the connection pipe 300 or 300 '. The valve 111a may include a swab-able valve 111a. The swabble valve 111a includes a surface forming a hole that is open when pressed from the outside. The swabble valve 111a is configured so that a user can wipe the surface of the swabble valve.

펌핑 모듈(100)은 챔버(110) 내부의 액체를 가압하는 가압 유닛(120)을 포함한다. 가압 유닛(120)은 챔버(110) 내부에 배치될 수 있다. 가압 유닛(120)은 챔버(110)의 상기 내부 공간을 마주보는 가압면(122)을 포함한다. 가압면(122)은 챔버(110) 내부의 액체와 접촉하여, 액체를 직접 밀어줄 수 있다. 가압면(122)은, 소정의 가압 방향(Ap1)으로 이동함으로써, 챔버(110) 내부의 액체를 가압할 수 있다. 챔버(110) 내부로 액체가 충전되는 중일 때, 가압면(122)은 상기 가압 방향(Ap1)의 반대 방향(Ap2)으로 이동한다. 도 1a 및 도 1b에는, 120A를 참고하여, 가압면(122) 및 슬라이딩부(121)가 상기 반대 방향(Ap2)으로 이동한 상태의 위치가 도시된다.The pumping module 100 includes a pressurization unit 120 that pressurizes the liquid within the chamber 110. The pressure unit 120 may be disposed within the chamber 110. The pressing unit 120 includes a pressing surface 122 facing the inner space of the chamber 110. The pressing surface 122 may contact the liquid inside the chamber 110 and push the liquid directly. The pressing surface 122 can pressurize the liquid in the chamber 110 by moving in the predetermined pressing direction Ap1. When the liquid is being filled into the chamber 110, the pressing surface 122 moves in the opposite direction Ap2 of the pressing direction Ap1. 1A and 1B, the position in which the pressing surface 122 and the sliding portion 121 are moved in the opposite direction Ap2 is shown with reference to 120A.

가압 유닛(120)은 챔버(110)의 내측면을 미끄러지며 이동하게 구성되는 슬라이딩부(121)를 포함한다. 슬라이딩부(121)는 가압면(122)과 일체로 이동하게 구성된다. 슬라이딩부(121)는, 챔버(110) 내부의 액체가 가압면(122)과 챔버(110)의 내측면 사이로의 누출되는 것을 방지하도록 구성될 수 있다.The pressurizing unit 120 includes a sliding portion 121 configured to slide and move on the inner surface of the chamber 110. The sliding portion 121 is configured to move integrally with the pressing surface 122. The sliding portion 121 may be configured to prevent liquid in the chamber 110 from leaking between the pressing surface 122 and the inner surface of the chamber 110. [

가압 유닛(120)은 가압면(122)이 상기 가압 방향(Ap1)으로 이동하도록 동력을 제공하는 가압 동작부(123)를 포함할 수 있다. 일 예로, 가압 동작부(123)는, 가스(gas) 활성(activation)에 의한 부피 팽창을 이용하여 챔버(110) 내의 액체를 가압하도록 구성될 수 있다. 다른 예로, 가압 동작부(123)는 사용자가 잡을 수 있는 부분을 제공하여, 사용자의 힘으로 가압면(122)을 상기 가압 방향(Ap1)으로 이동시킬 수 있다.The pressurizing unit 120 may include a pressurizing operation portion 123 that provides power to move the pressing surface 122 in the press direction Ap1. For example, the pressurizing portion 123 may be configured to pressurize the liquid in the chamber 110 using volume expansion by gas activation. As another example, the pressing operation portion 123 may provide a portion that can be held by the user, so that the user can move the pressing surface 122 in the pressing direction Ap1.

도시되지는 않았으나, 다른 예로, 가압 유닛(120)는, 벌룬(balloon) 등의 탄성체의 탄성력을 이용하여 액체를 가압하도록 구성될 수 있다. 이 경우, 가압 유닛(120)은 상기 벌룬 내의 액체가 가압되도록 구성될 수 있다.Although not shown, as another example, the pressing unit 120 can be configured to pressurize the liquid using the elastic force of an elastic body such as a balloon. In this case, the pressurizing unit 120 may be configured to pressurize the liquid in the balloon.

포트 모듈(200, 200')은 챔버(110) 내로 액체를 충전 가능하도록 구성된다. 액체가 외부로부터 포트 모듈(200, 200')을 통해 연결 관(300, 300') 또는 챔버(110)로 유입될 수 있다. 포트 모듈(200, 200')은 연결 관(300, 300') 또는 챔버(110)에 연결된다.The port modules 200 and 200 'are configured to be capable of filling liquid into the chamber 110. Liquid can be introduced from the outside into the connection pipe 300 or 300 'or the chamber 110 through the port module 200 or 200'. The port modules 200 and 200 'are connected to the connection tubes 300 and 300' or the chamber 110.

연결 관(300, 300') 내로 액체가 이동할 수 있다. 연결 관(300, 300')의 상류 측 말단은 펌핑 모듈(100)에 연결된다. 연결 관(300, 300')의 하류 측 말단은 플러싱 장치(700, 700', 700'', 700''', 700'''')에 연결된다. 연결 관(300, 300')은 펌핑 모듈(100)로부터 플러싱 장치(700, 700', 700'', 700''', 700'''')까지 상기 위험 약액의 이동을 안내한다. 연결 관(300, 300')은 플렉서블(flexible)한 재질로 형성될 수 있다.The liquid can move into the connection pipe 300, 300 '. The upstream ends of the connectors 300, 300 'are connected to the pumping module 100. The downstream ends of the connectors 300 and 300 'are connected to the flushing devices 700, 700', 700 '', 700 '' ', and 700' '' '. The connectors 300 and 300 'guide the movement of the hazardous liquid from the pumping module 100 to the flushing apparatus 700, 700', 700 '', 700 '' ', 700' '' '. The connectors 300 and 300 'may be formed of a flexible material.

위험 약액 주입 장치(1, 1')는 배출 포트부(111)에 연결되는 모듈 연결부(350)를 포함한다. 모듈 연결부(350)를 통해 배출 포트부(111)로부터 배출된 액체가 연결 관(300, 300') 내로 유입될 수 있다.The apparatus for injecting dangerous chemical liquid 1, 1 'includes a module connection part 350 connected to the discharge port part 111. The liquid discharged from the discharge port portion 111 through the module connection portion 350 can be introduced into the connection pipes 300 and 300 '.

본 실시예에서, 모듈 연결부(350)는 배출 포트부(111)에 사용자에 의해 결합되도록 구성될 수 있다. 모듈 연결부(350)는, 한번 배출 포트부(111)에 결합되면 사용자에 의해 일반적인 방식으로 분리 불가능하도록 구성될 수 있다. 구체적으로, 최초에 모듈 연결부(350)가 배출 포트부(111)와 분리된 상태에서, 배출 포트부(111)는 밸브(111a)에 의해 닫힘 상태를 유지한다. 모듈 연결부(350)가 배출 포트부(111)에 결합된 상태에서, 모듈 연결부(350)의 일 부분이 밸브(111a)를 누르고, 이에 따라 닫혀있던 배출 포트부(111)가 열린다. 배출 포트부(111)의 열림 상태에서, 챔버(110) 내부의 액체가 배출 포트부(111)를 통해 연결 관(300, 300') 내로 유입될 수 있다. 모듈 연결부(350)는, 사용자에 의해 모듈 연결부(350)가 배출 포트부(111)에 한번 결합되면, 사용자에 의해 일반적인 방식으로 분리가 불가능하도록 구성될 수 있다.In this embodiment, the module connection portion 350 may be configured to be coupled to the discharge port portion 111 by the user. The module connection part 350 may be configured such that it can not be separated by the user in a general manner once it is coupled to the discharge port part 111. [ Specifically, in a state where the module connecting portion 350 is initially separated from the discharge port portion 111, the discharge port portion 111 is kept closed by the valve 111a. In a state where the module connecting portion 350 is coupled to the discharge port portion 111, a part of the module connecting portion 350 presses the valve 111a, and thus the discharge port portion 111 which has been closed is opened. The liquid inside the chamber 110 can be introduced into the connection pipes 300 and 300 'through the discharge port portion 111 in the open state of the discharge port portion 111. [ The module connection portion 350 may be configured such that when the module connection portion 350 is once coupled to the discharge port portion 111 by the user, the module connection portion 350 can not be separated by the user in a general manner.

도시되지는 않았으나 다른 예에서, 사용자에 의한 별도 결합 과정없이, 배출 포트부(111)에 연결 관(300, 300')의 상류 측 말단이 본딩(bonding)된 상태로 실시될 수 있다. 이 경우에는, 배출 포트부(111)에 별도의 밸브가 배치되지 않을 수 있다.Although not shown, in another example, the upstream end of the connection pipe 300, 300 'may be bonded to the discharge port portion 111 without a separate joining process by a user. In this case, a separate valve may not be disposed in the discharge port portion 111.

적어도 하나의 연결관 개폐 모듈(400, 400')이 구성될 수 있다. 본 실시예에서, 연결관 개폐 모듈(400, 400')은 연결 관(300, 300')의 외부를 눌러주어 연결 관(300, 300') 중 일 지점의 액체의 흐름을 막아줄 수 있다. 연결관 개폐 모듈(400, 400')은 연결관 삽입 홈(400h)을 형성할 수 있다. 연결 관(300, 300')의 일부가 연결관 삽입 홈(400h)에 삽입됨으로써, 연결 관(300, 300')의 상기 일부가 통로의 닫힘 상태가 될 수 있다.At least one connection and disconnection module 400, 400 'may be configured. In this embodiment, the connection pipe opening and closing modules 400 and 400 'can press the outside of the connection pipes 300 and 300' to block the flow of the liquid at one point of the connection pipes 300 and 300 '. The connector open / close modules 400 and 400 'may form a connector insertion groove 400h. A part of the coupling pipes 300 and 300 'is inserted into the coupling pipe insertion groove 400h so that the part of the coupling pipes 300 and 300' can be in the closed state of the passage.

필터 모듈(500)은 연결 관(300, 300')에 배치될 수 있다. 필터 모듈(500)은 양단이 각각 연결 관(300, 300')에 연결된 필터 케이싱(510)을 포함한다. 필터 케이싱(510)은 양단에 연결된 연결 관(300, 300')이 형성하는 유로를 연속적으로 연결해주는 통로를 형성한다. 필터 모듈(500)은 필터 케이싱(510)의 상기 통로 내에 배치되는 필터(520)를 포함한다.The filter module 500 may be disposed in the coupling tube 300, 300 '. The filter module 500 includes a filter casing 510 having both ends connected to the connection pipes 300 and 300 ', respectively. The filter casing 510 forms a passage for continuously connecting the flow paths formed by the connection pipes 300 and 300 'connected to both ends. The filter module 500 includes a filter 520 disposed in the passageway of the filter casing 510.

환자 연결 모듈(600, 600')은 플러싱 장치(700, 700', 700'', 700''', 700'''')에 연결될 수 있다. 환자 연결 모듈(600, 600')은 플러싱 장치(700, 700', 700'', 700''', 700'''')에 분리 가능하게 결합될 수 있다. 플러싱 장치(700, 700', 700'', 700''', 700'''')의 내부를 통과한 액체는 환자 연결 모듈(600, 600')로 이동하여, 환자의 체내로 유입될 수 있다.The patient connection modules 600 and 600 'may be connected to the flushing devices 700, 700', 700 '', 700 '' ', and 700' '' '. The patient connection modules 600 and 600 'may be releasably coupled to the flushing devices 700, 700', 700 '', 700 '' ', and 700' '' '. The liquid that has passed through the interior of the flushing device 700, 700 ', 700' ', 700' '', 700 '' '' may move into the patient connection module 600 or 600 ' have.

환자 연결 모듈(600, 600')은 환자의 피부에 침습 가능하게 구성된 주사 바늘(610)을 포함할 수 있다. 환자 연결 모듈(600, 600')은 주사 바늘(610)을 지지하는 주사 지지부(620)를 포함한다.The patient connection module 600, 600 'may include an injection needle 610 configured to be infiltrable to the skin of the patient. The patient connection module 600, 600 'includes a scan support 620 that supports the injection needle 610.

환자 연결 모듈(600, 600')은 플러싱 장치(700, 700', 700'', 700''', 700'''')의 하류부(713)와 결합되는 모듈 결합부(630)를 포함한다. 모듈 결합부(630)는 후술할 플러싱 장치의 교체 결합부(770)와 분리 가능하게 결합될 수 있다. 모듈 결합부(630)와 교체 결합부(770) 중 어느 하나는 수(male) 스크류를 형성하고, 다른 하나는 상기 수 스크류와 맞물리는 암(female) 스크류를 형성할 수 있다. 도 1a 및 도 1b의 화살표 C2는 모듈 결합부(630)의 하류부(713)에 대한 결합/분리 방향을 도시한다.The patient connection module 600, 600 'includes a module coupling portion 630 coupled with the downstream portion 713 of the flushing device 700, 700', 700 ", 700 '' ', 700" . The module coupling portion 630 may be detachably coupled to the replacement coupling portion 770 of the flushing device to be described later. Either the module coupling portion 630 or the replacement coupling portion 770 may form a male screw and the other may form a female screw to be engaged with the male screw. Arrows C2 in Figs. 1A and 1B show the coupling / separation direction of the module coupling portion 630 with respect to the downstream portion 713. Fig.

일 예로, 환자 연결 모듈(600)은 주사 바늘(610), 주사 지지부(620) 및 모듈 결합부(630)가 순차적으로 연결되어 구성될 수 있다. 이 경우, 플러싱 장치(700, 700', 700'', 700''', 700'''')의 하류부(713)로부터 유출된 액체가 순차적으로 모듈 결합부(630), 주사 지지부(620) 및 주사 바늘(610)을 통과하여 환자의 체내로 유입될 수 있다.For example, the patient connection module 600 may be configured such that the injection needle 610, the scan support portion 620, and the module coupling portion 630 are sequentially connected. In this case, the liquid flowing out from the downstream portion 713 of the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' sequentially flows in the module coupling portion 630, And the injection needle 610 and into the patient's body.

다른 예로, 환자 연결 모듈(600')은 모듈 결합부(630)의 하류 측에 연결되는 환자 연결관 고정부(650')를 더 포함한다. 환자 연결 모듈(600')은 환자 연결관 고정부(650')와 주사 지지부(620)를 연결하는 환자 연결관(640')을 더 포함한다. 환자 연결관(640')은 플렉서블(flexible)한 재질로 형성될 수 있다. 환자 연결 모듈(600')은 주사 바늘(610), 주사 지지부(620), 환자 연결관(640'), 환자 연결관 고정부(650') 및 모듈 결합부(630)가 순차적으로 연결되어 구성될 수 있다. 이 경우, 플러싱 장치(700, 700', 700'', 700''', 700'''')의 하류부(713)로부터 유출된 액체가 순차적으로 모듈 결합부(630), 환자 연결관 고정부(650'), 환자 연결관(640'), 주사 지지부(620) 및 주사 바늘(610)을 통과하여 환자의 체내로 유입될 수 있다. 예를 들어, 상기 인입 부품은 주사 바늘(610) 및 주사 지지부(620)로 구성되고, 상기 나머지 부품은 모듈 결합부(630), 환자 연결관 고정부(650') 및 환자 연결관(640')로 구성될 수 있다.In another example, the patient connection module 600 'further includes a patient connector fixation portion 650' connected to the downstream side of the module connector portion 630. The patient connection module 600 'further includes a patient connector 640' connecting the patient connector fixing portion 650 'and the scan support portion 620. The patient connector 640 'may be formed of a flexible material. The patient connection module 600 'is formed by sequentially connecting the injection needle 610, the scan support portion 620, the patient connection tube 640', the patient connection tube fixing portion 650 ', and the module coupling portion 630 . In this case, the liquid flowing out from the downstream portion 713 of the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' is sequentially transferred to the module connecting portion 630, The patient's connection tube 640 ', the scan support 620, and the injection needle 610 and into the patient's body. For example, the inflow part is composed of the injection needle 610 and the scan support part 620, and the remaining part is connected to the module coupling part 630, the patient connector fixing part 650 'and the patient connector 640' ).

도 1a 및 도 1b를 참고하여, 플러싱 장치(700, 700', 700'', 700''', 700'''')는 상기 제1 유로(P1)를 형성하는 메인 바디(710)를 포함한다. 메인 바디(710)는 상기 제2 유로(P2)를 형성한다. 또한, 메인 바디(710)는 상기 상류 유로부(P1a)를 형성하는 상류부(711)를 포함한다. 메인 바디(710)는 상기 하류 유로부(P1b)를 형성하는 하류 유로부(P1b)를 포함한다. 메인 바디(710)는 상기 제2 유로(P2)를 형성하는 플러싱부(715)를 포함한다.Referring to FIGS. 1A and 1B, the flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a main body 710 forming the first flow path P1 do. The main body 710 forms the second flow path P2. Further, the main body 710 includes an upstream portion 711 forming the upstream passage portion P1a. The main body 710 includes a downstream passage portion P1b forming the downstream passage portion P1b. The main body 710 includes a flushing portion 715 forming the second flow path P2.

플러싱 장치(700, 700', 700'', 700''', 700'''')는 플러싱부(715)에 결합되는 플러싱 밸브 유닛(720)을 포함한다. 플러싱 밸브 유닛(720)은 제2 유로(P2)를 개폐 가능하게 구성된다. 실시예에 따라, 플러싱 밸브 유닛(720)은 플러싱부(715)에 분리 가능하게 결합될 수 있다.The flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a flushing valve unit 720 coupled to the flushing unit 715. The flushing valve unit 720 is configured to be capable of opening and closing the second flow path P2. According to an embodiment, the flushing valve unit 720 may be releasably coupled to the flushing portion 715. [

플러싱 장치(700, 700', 700'', 700''', 700'''')는 플러싱 밸브 유닛(720)에 분리 가능하게 결합되는 플러싱 포트 개폐부(740)를 포함한다. 도 1a 및 도 1b의 화살표 D1은, 플러싱 포트 개폐부(740)의 플러싱 밸브 유닛(720)에 대한 결합/분리 방향을 도시한다.The flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' includes a flushing port opening / closing portion 740 detachably coupled to the flushing valve unit 720. Arrows D1 in Figs. 1A and 1B show the engagement / disengagement direction of the flushing port opening / closing part 740 with respect to the flushing valve unit 720. Fig.

플러싱 장치(700, 700', 700'', 700''', 700'''')는 환자 연결 모듈(600, 600')과 분리 가능하게 결합되는 교체 결합부(770)를 포함한다. 교체 결합부(770)는 하류부(713)에 배치된다.The flushing device 700, 700 ', 700' ', 700' '', 700 '' '' includes a replacement coupling portion 770 removably coupled to the patient connection module 600 and 600 '. The replacement engaging portion 770 is disposed at the downstream portion 713.

플러싱 장치(700, 700', 700'', 700''', 700'''')는 교체 결합부(770)에 분리 가능하게 결합되는 하류 벤트 캡(780)을 더 포함할 수 있다. 하류 벤트 캡(780)은 환자 연결 모듈(600, 600')과 교체 가능하게 교체 결합부(770)에 결합될 수 있다. 도 1a 및 도 1b의 화살표 C1은, 하류 벤트 캡(780)의 하류부(713)에 대한 결합/분리 방향을 도시한다.The flushing apparatus 700, 700 ', 700' ', 700' '', 700 '' '' may further include a downstream vent cap 780 detachably coupled to the replaceable engagement portion 770. The downstream vent cap 780 may be coupled to the replaceable engagement portion 770 interchangeably with the patient connection module 600, 600 '. Arrows C1 in Figures 1a and 1b show the engagement / disengagement direction of the downstream vent cap 780 with respect to the downstream portion 713.

이하, 도 1a를 참고하여, 일 실시예에 따른 위험 약액 주입 장치(1)를 다른 일 실시예와의 차이점을 중심으로 설명하면 다음과 같다.Hereinafter, with reference to FIG. 1A, the dangerous chemical liquid injector 1 according to one embodiment will be described with reference to the differences from the other embodiments.

일 실시예에 따른 포트 모듈(200)은 연결 관(300) 상에 배치된다. 포트 모듈(200)은 제1 연결부(310)의 하류 측 말단에 연결되는 제1 연장부(210)를 포함한다. 제1 연장부(210)의 말단에 제1 포트(210a)가 형성된다. 제1 포트(210a)를 통해, 제1 연장부(210) 내의 액체가 제1 연결부(310) 내로 이동하거나 제1 연결부(310) 내의 액체가 제1 연장부(210) 내로 이동할 수 있다. 포트 모듈(200)은 제2 연결부(320)의 상류 측 말단에 연결되는 제2 연장부(220)를 포함한다. 제2 연장부(220)의 말단에 제2 포트(220a)가 형성된다. 제2 포트(220a)를 통해, 제2 연장부(220) 내의 액체가 제2 연결부(320) 내로 이동할 수 있다.The port module 200 according to one embodiment is disposed on the connector tube 300. The port module 200 includes a first extension portion 210 connected to a downstream end of the first connection portion 310. A first port 210a is formed at the distal end of the first extension 210. The liquid in the first extension 210 can move into the first connection 310 or the liquid in the first connection 310 can move into the first extension 210 through the first port 210a. The port module 200 includes a second extension 220 connected to the upstream end of the second connection 320. And a second port 220a is formed at the end of the second extension 220. [ Through the second port 220a, the liquid in the second extension 220 can move into the second connection 320. [

포트 모듈(200)은 외부로부터 액체가 유입 가능하도록 구성된 유입부(230)를 포함한다. 유입부(230)의 말단에 유입 포트(230a)가 형성된다. 유입 포트(230a)를 통해 외부의 액체가 유입부(230) 내로 이동할 수 있다.The port module 200 includes an inlet 230 configured to allow liquid to flow from the outside. An inlet port 230a is formed at the end of the inlet 230. External liquid can flow into the inlet 230 through the inlet port 230a.

포트 모듈(200)은, 유입 포트(230a)에 배치된 스웨버블 밸브(swabable valve)(231)를 포함할 수 있다. 스웨버블 밸브(231)는 유입 포트(230a)에 주사기 팁(tip)이 가압된 경우, 유입 포트(230a)를 열어주도록 구성될 수 있다.The port module 200 may include a swabable valve 231 disposed at the inlet port 230a. The swabble valve 231 may be configured to open the inlet port 230a when the syringe tip is pressed against the inlet port 230a.

포트 모듈(200)은, 유입부(230)에 분리 가능하게 결합되도록 구성된 유입 포트 개폐부(240)를 포함한다. 유입 포트 개폐부(240)가 유입부(230)에 결합된 상태에서 유입 포트 개폐부(240)가 스웨버블 밸브(231)의 상기 표면을 덮어줌으로써, 장치의 위생성을 향상시킬 수 있다. 도 1a의 화살표 E1은, 유입 포트 개폐부(240)의 유입부(230)에 대한 결합/분리 방향을 도시한다.The port module 200 includes an inlet port opening / closing portion 240 configured to be detachably coupled to the inlet portion 230. The inflow port opening / closing part 240 covers the surface of the swabble valve 231 in a state where the inflow port opening / closing part 240 is coupled to the inflow part 230, thereby improving the sanitary property of the device. Arrow E1 in FIG. 1A shows the direction of engagement / disengagement of the inlet port opening / closing portion 240 with respect to the inlet portion 230. FIG.

일 실시예에 따른 연결 관(300)은, 배출 포트부(111)와 포트 모듈(200)의 제1 연장부(210)를 연결하는 제1 연결부(310)를 포함한다. 연결 관(300)은, 포트 모듈(200)의 제2 연장부(220)와 필터 모듈(500)을 연결하는 제2 연결부(320)를 포함한다. 연결 관(300)은, 필터 모듈(500)과 플러싱 장치(700, 700', 700'', 700''', 700'''')의 상류부(711)를 연결하는 제3 연결부(330)를 포함한다.The connection pipe 300 according to an embodiment includes a first connection portion 310 connecting the discharge port portion 111 and the first extension portion 210 of the port module 200. The connector 300 includes a second connector 320 connecting the second extension 220 of the port module 200 and the filter module 500. The connection pipe 300 includes a third connection part 330 for connecting the filter module 500 and the upstream part 711 of the flushing device 700, 700 ', 700' ', 700' '', 700 ' ).

일 실시예에 따른 연결관 개폐 모듈(400)은 제1 연결부(310)의 일 지점(B1)의 개폐 여부를 변경할 수 있는 제1 개폐 모듈(410)을 포함한다. 연결관 개폐 모듈(400)은 제2 연결부(320)의 일 지점(B2)의 개폐 여부를 변경할 수 있는 제2 개폐 모듈(420)을 포함한다.The connector opening and closing module 400 according to one embodiment includes a first opening and closing module 410 that can change whether one point B1 of the first connecting part 310 is open or closed. The connector open / close module 400 includes a second open / close module 420 that can change whether one end B2 of the second connector 320 is open or closed.

도 1a를 참고한 일 실시예에서, 상기 프라이밍 단계, 약액 주입 단계 및 플러싱 단계를 설명하면 다음과 같다. 일 실시예에 따른 프라이밍 단계에서, 유입 포트 개폐부(240)를 유입부(230)로부터 분리하고, 제1 연결관 개폐 모듈(410)로 제1 연결부(310)의 통로(B1 참고)를 차단하며, 제1 연결부(310)를 제외한 연결 관(300)의 나머지 부분의 통로는 개방한다. 화살표 F1, F3 및 F4를 참고하여, 외부로부터 유입 포트(230a)로 프라이밍용 액체를 유입시키면, 프라이밍용 액체는 유입부(230), 제2 연장부(220), 제2 연결부(330), 제3 연결부(330) 및 제1 유로(P1)를 순차적으로 흐름으로써, 연결 관(300)의 대부분 및 제1 유로(P1)의 내부가 상기 프라이밍용 액체로 채워진다.In the embodiment of FIG. 1A, the priming step, the chemical solution injecting step, and the flushing step will be described as follows. In the priming step according to the embodiment, the inflow port opening / closing part 240 is separated from the inflow part 230, the first connection opening / closing module 410 blocks the passage (see B1) of the first connection part 310 , The passage of the remaining part of the connection pipe 300 except for the first connection part 310 is opened. Referring to the arrows F1, F3 and F4, when the priming liquid is flowed from the outside to the inlet port 230a, the priming liquid flows into the inlet 230, the second extension 220, the second connection 330, The majority of the connection pipe 300 and the interior of the first flow path P1 are filled with the priming liquid by sequentially flowing the third connection part 330 and the first flow path P1.

상기 프라이밍 단계에서, 제2 유로(P2)에 남아있는 공기를 제거하기 위하여, 추가적으로 플러싱 포트 개폐부(740)를 플러싱 밸브 유닛(720)으로부터 분리한 뒤, 외부로부터 플러싱 밸브 유닛(720)으로 프라이밍용 액체를 유입시킬 수 있다. 화살표 F5를 참고하여, 플러싱 밸브 유닛(720)으로 유입된 프라이밍용 액체가 제2 유로(P2) 및 하류 유로부(P1b)를 순차적으로 흐름으로써, 제2 유로(P2)의 내부가 상기 프라이밍용 액체로 채워진다. 이 경우, 제2 유로(P2) 내에 있던 공기는 하류부(713)를 통해 외부로 배출될 수 있다.In order to remove the air remaining in the second flow path P2 in the priming step, the flushing valve unit 720 is further separated from the flushing valve unit 720 and then discharged from the outside to the flushing valve unit 720 for priming Liquid can be introduced. The priming liquid flowing into the flushing valve unit 720 sequentially flows through the second flow path P2 and the downstream flow path portion P1b so that the inside of the second flow path P2 is filled with the priming liquid It is filled with liquid. In this case, the air in the second flow path P2 can be discharged to the outside through the downstream portion 713. [

상기 프라이밍 단계에서, 제2 유로(P2)에 남아있는 공기를 제거하기 위하여, 후술할 제5 실시예(도 11 참고)에 따라 플러싱부(715)에 플러싱 밸브 유닛(720) 대신 후술할 플러싱 벤트 캡(730)을 결합한 상태에서는, 연결 관(300)으로부터 상류 유로부(P1a)로 유입된 프라이밍용 액체 중, 일부는 상류 유로부(P1a)를 거쳐 하류 유로부(P1b)로 흐르고(화살표 F4 참고), 다른 일부는 상류 유로부(P1a)를 거쳐 제2 유로(P2)로도 흐른다(화살표 F6 참고). 이 경우, 제2 유로(P2) 내에 있던 공기는 플러싱 벤트 캡(730)을 통해 외부로 배출될 수 있다. 이를 통해, 약액 주입 장치의 2이상의 위치에서 상기 프라이밍용 액체를 외부로부터 유입시키는 작업이 불요하게 되므로, 의료진이 더욱 편리하게 약액 주입 장치를 사용할 수 있다.In order to remove air remaining in the second flow path P2 in the priming step, a flushing vent unit 720 may be replaced with a flushing vent unit 720 in place of the flushing valve unit 720 in accordance with a fifth embodiment (see FIG. 11) A portion of the priming liquid that has flowed from the connection pipe 300 into the upstream flow path portion P1a flows into the downstream flow path portion P1b through the upstream flow path portion P1a And the other part flows to the second flow path P2 via the upstream flow path portion P1a (see arrow F6). In this case, the air in the second flow path P2 can be discharged to the outside through the flushing cap cap 730. [ This makes it unnecessary for the priming liquid to be introduced from the outside at two or more positions of the liquid medicament injecting apparatus, so that the medicinal liquid injecting apparatus can be more conveniently used by the medical staff.

일 실시예에서, 상기 프라이밍 단계 후 상기 약액 주입 단계가 진행된다. 일 실시예에 따른 약액 주입 단계에서, 유입 포트 개폐부(240)의 유입부(230)로부터 분리하고, 제2 연결관 개폐 모듈(420)로 제2 연결부(320)의 통로를 차단하며, 제1 연결관 개폐 모듈(410)을 제1 연결부(310)로부터 분리하여 제1 연결부(310)를 개방한다. 또한, 플러싱 포트 개폐부(740)를 플러싱 밸브 유닛(720)에 결합시켜 플러싱 포트(715a)를 차단한다. 화살표 F0을 참고하여, 외부로부터 유입 포트(230a)로 상기 위험 약액을 유입시키면, 상기 위험 약액은 유입부(230) 및 제1 연장부(210)를 거쳐 제1 연결부(310)로 유입된다. 제1 연결부(310)로부터 챔버(110) 내로 위험 약액이 유입되면서, 가압면(122)은 상기 방향(Ap2)로 이동한다. 그 후, 유입 포트 개폐부(240)를 유입부(230)에 결합시켜 유입 포트(230a)를 차단하고, 제2 연결관 개폐 모듈(420)을 제2 연결부(320)로부터 분리하여 연결 관(300)을 개방 상태로 만든다. 화살표 F2, F3 및 F4를 참고하여, 그 후 가압면(122)을 상기 가압 방향(Ap1)으로 이동시켜, 위험 약액이 연결 관(300), 플러싱 장치(700, 700', 700'', 700''', 700'''') 및 환자 연결 모듈(600, 600')을 순차적으로 통과한 후 환자의 체내로 유입된다.In one embodiment, the chemical liquid injection step is performed after the priming step. In the chemical solution injecting step according to the embodiment, the inlet port opening / closing part 240 is separated from the inlet part 230, the second connection pipe opening / closing module 420 blocks the passage of the second connection part 320, The connector opening / closing module 410 is separated from the first connecting portion 310 to open the first connecting portion 310. [ Further, the flushing port opening / closing unit 740 is coupled to the flushing valve unit 720 to block the flushing port 715a. The dangerous liquid medicine flows into the first connection part 310 through the inflow part 230 and the first extension part 210 when the dangerous liquid medicine is introduced into the inflow port 230a from the outside with reference to the arrow F0. As the dangerous chemical liquid flows into the chamber 110 from the first connection part 310, the pressing surface 122 moves in the direction Ap2. Thereafter, the inflow port opening / closing part 240 is coupled to the inflow part 230 to block the inflow port 230a, the second connection pipe opening / closing module 420 is separated from the second connection part 320, ) To an open state. The pressure applying surface 122 is moved in the pressing direction Ap1 with reference to the arrows F2, F3 and F4 so that the dangerous chemical liquid flows through the connecting pipe 300, the flushing devices 700, 700 ', 700' '' ', 700' '' ') and the patient connection module 600, 600', and then flows into the patient's body.

일 실시예에서, 상기 약액 주입 단계 후 상기 플러싱 단계가 진행된다. 일 실시예에 따른 플러싱 단계에서, 플러싱 포트 개폐부(740)를 플러싱 밸브 유닛(720)으로부터 분리한 뒤, 외부로부터 플러싱 밸브 유닛(720)으로 플러싱용 액체를 유입시킬 수 있다. 화살표 F5를 참고하여, 플러싱 밸브 유닛(720)으로 유입된 플러싱용 액체가 제2 유로(P2), 하류 유로부(P1b) 및 환자 연결 모듈(600, 600')을 순차적으로 흐름으로써, 환자의 체내로 플러싱용 액체가 유입되기 시작하면 상기 플러싱 단계가 종료된다.In one embodiment, the flushing step is performed after the chemical liquid injection step. In the flushing step according to the embodiment, after the flushing port opening and closing part 740 is separated from the flushing valve unit 720, the flushing liquid can be introduced into the flushing valve unit 720 from the outside. The flushing liquid flowing into the flushing valve unit 720 sequentially flows through the second flow path P2, the downstream flow path portion P1b and the patient connection modules 600 and 600 'with reference to the arrow F5, When the flushing liquid starts to flow into the body, the flushing step ends.

이하, 도 1b를 참고하여, 다른 일 실시예에 따른 위험 약액 주입 장치(1')를 일 실시예와의 차이점을 중심으로 설명하면 다음과 같다. 다른 일 실시예에 따른 포트 모듈(200')은 챔버(110)의 외부 표면에 배치된다. 포트 모듈(200')은, 챔버(110)의 외부와 내부 공간을 연결해주는 통로를 형성한다. 포트 모듈(200')은, 액체가 포트 모듈(200')을 통해 챔버(110)의 내부 공간으로 유입될 수 있도록 구성된다.Hereinafter, with reference to FIG. 1B, a description will be given of a dangerous chemical liquid injecting apparatus 1 'according to another embodiment with reference to a difference from the embodiment. The port module 200 'according to another embodiment is disposed on the outer surface of the chamber 110. The port module 200 'forms a passage connecting the outside of the chamber 110 and the inner space. The port module 200 'is configured such that liquid can flow into the interior space of the chamber 110 through the port module 200'.

포트 모듈(200')은 외부로부터 액체가 유입 가능하도록 구성된 유입부(230')를 포함한다. 유입부(230')의 말단에 유입 포트(230a')가 형성된다. 유입 포트(230a')를 통해 외부의 액체가 유입부(230') 내로 이동할 수 있다.The port module 200 'includes an inlet 230' configured to allow liquid to flow from the outside. An inlet port 230a 'is formed at the end of the inlet 230'. External liquid can flow into the inlet 230 'through the inlet port 230a'.

포트 모듈(200')은, 유입 포트(230a')에 배치된 스웨버블 밸브(231')를 포함할 수 있다. 포트 모듈(200')은, 유입부(230')에 분리 가능하게 결합되는 유입 포트 개폐부(240')를 포함한다. 도 1a의 화살표 E1'은, 유입 포트 개폐부(240')의 유입부(230')에 대한 결합/분리 방향을 도시한다.The port module 200 'may include a swivel valve 231' disposed at the inlet port 230a '. The port module 200 'includes an inlet port opening / closing portion 240' that is detachably coupled to the inlet portion 230 '. Arrow E1 'in FIG. 1A shows the direction of engagement / disengagement of the inlet port opening / closing portion 240' with respect to the inlet portion 230 '.

다른 일 실시예에 따른 연결 관(300')은, 배출 포트부(111)와 필터 모듈(500)을 연결하는 필터 상류 연결부(315')를 포함한다. 연결 관(300')은, 필터 모듈(500)과 플러싱 장치의 상류부(711)를 연결하는 필터 하류 연결부(330)를 포함한다.The connection pipe 300 'according to another embodiment includes a filter upstream connection portion 315' connecting the discharge port portion 111 and the filter module 500. The connector 300 'includes a filter downstream connection 330 connecting the filter module 500 and the upstream portion 711 of the flushing device.

다른 일 실시예에 따른 연결관 개폐 모듈(400')은 필터 상류 연결부(315')의 일 지점(B1')의 개폐 여부를 변경할 수 있다.The connection pipe opening / closing module 400 'according to another embodiment can change whether the one point B1' of the filter upstream connection portion 315 'is open or closed.

도 1b를 참고한 다른 일 실시예에서, 상기 프라이밍 단계 및 약액 주입 단계를 설명하면 다음과 같다. 다른 일 실시예의 상기 플러싱 단계에 대해서는, 상기 일 실시예의 내용과 동일하여 설명을 생략한다. 다른 일 실시예에 따른 프라이밍 단계에서, 유입 포트 개폐부(240')를 유입부(230')로부터 분리하고, 연결관 개폐 모듈(400)로 필터 상류 연결부(315')의 통로(B1' 참고)를 차단한다. 화살표 F0'을 참고하여, 외부로부터 유입 포트(230a')로 상기 프라이밍용 액체를 유입시키면, 상기 프라이밍용 액체는 유입부(230')를 거쳐 챔버(110) 내로 상기 프라이밍용 액체가 유입되면서, 가압면(122)은 상기 반대 방향(Ap2)로 이동한다. 그 후, 유입 포트 개폐부(240')를 유입부(230')에 결합시켜 유입 포트(230a')를 차단하고, 연결관 개폐 모듈(400)을 필터 상류 연결부(315')로부터 분리하여 연결 관(300)을 개방 상태로 만든다. 화살표 F2, F3 및 F4를 참고하여, 그 후 가압면(122)을 상기 가압 방향(Ap1)으로 이동시켜, 상기 프라이밍용 액체는 배출 포트부(111), 필터 상류 연결부(315'), 필터 하류 연결부(330) 및 제1 유로(P1)를 순차적으로 흐름으로써, 연결 관(300') 및 제1 유로(P1)의 내부가 상기 프라이밍용 액체로 채워진다. 그 밖에, 상기 프라이밍 단계에서 제2 유로(P2) 내의 공기를 제거하는 구성/방법에 대한 내용은 일 실시예와 같아, 그 설명을 생략한다.In another embodiment, referring to FIG. 1B, the priming step and the chemical solution injecting step will be described as follows. The flushing step of the other embodiment is the same as that of the above embodiment, and the description thereof will be omitted. In the priming step according to another embodiment, the inflow port switching part 240 'is separated from the inflow part 230', and the connection pipe opening / closing module 400 connects the passage B1 'of the filter upstream connection part 315' . Referring to the arrow F0 ', when the priming liquid is introduced from the outside into the inlet port 230a', the priming liquid flows into the chamber 110 through the inlet 230 ' The pressing surface 122 moves in the opposite direction Ap2. Thereafter, the inflow port switching part 240 'is coupled to the inflow part 230' to block the inflow port 230a ', and the connection pipe opening / closing module 400 is separated from the filter upstream connection part 315' (300) to an open state. Referring to the arrows F2, F3 and F4, the pressing surface 122 is then moved in the pressing direction Ap1 so that the priming liquid passes through the discharge port portion 111, the filter upstream connecting portion 315 ' The interior of the connection pipe 300 'and the first flow path P1 is filled with the priming liquid by sequentially flowing the connection part 330 and the first flow path P1. In addition, the configuration / method of removing air in the second flow path P2 in the priming step is the same as that in the first embodiment, and a description thereof will be omitted.

다른 일 실시예에서, 상기 프라이밍 단계 후 상기 약액 주입 단계가 진행된다. 다른 일 실시예에 따른 약액 주입 단계에서, 유입 포트 개폐부(240')의 유입부(230')로부터 분리하고, 연결관 개폐 모듈(400)로 필터 상류 연결부(315')의 통로를 차단한다. 화살표 F0'을 참고하여, 외부로부터 유입 포트(230a')로 상기 위험 약액을 유입시키면, 상기 위험 약액은 유입부(230')를 거쳐 챔버(110) 내로 상기 위험 약액이 유입되면서, 가압면(122)은 상기 반대 방향(Ap2)로 이동한다. 그 후, 유입 포트 개폐부(240')를 유입부(230')에 결합시켜 유입 포트(230a')를 차단하고, 연결관 개폐 모듈(400)을 필터 상류 연결부(315')로부터 분리하여 연결 관(300)을 개방 상태로 만든다. 화살표 F2, F3 및 F4를 참고하여, 그 후 가압면(122)을 상기 가압 방향(Ap1)으로 이동시켜, 위험 약액이 연결 관(300'), 플러싱 장치(700, 700', 700'', 700''', 700'''') 및 환자 연결 모듈(600, 600')을 순차적으로 통과한 후 환자의 체내로 유입된다.In another embodiment, the chemical liquid injection step is performed after the priming step. In the chemical solution injecting step according to another embodiment, the inlet port opening / closing part 240 'is separated from the inlet part 230', and the connection pipe opening / closing module 400 blocks the passage of the filter upstream connection part 315 '. When the dangerous chemical solution flows into the inlet port 230a 'from the outside with reference to the arrow F0', the dangerous chemical liquid flows into the chamber 110 through the inlet 230 ' 122 move in the opposite direction Ap2. Thereafter, the inflow port switching part 240 'is coupled to the inflow part 230' to block the inflow port 230a ', and the connection pipe opening / closing module 400 is separated from the filter upstream connection part 315' (300) to an open state. The pressure applying surface 122 is moved in the pressing direction Ap1 with reference to the arrows F2, F3 and F4 so that the dangerous chemical liquid flows through the connecting pipe 300 ', the flushing apparatuses 700, 700', 700 ' 700 '' ', 700' '' ') and the patient connection module 600, 600', and then flows into the patient's body.

이하, 도 2 내지 도 4를 참고하여, 본 개시의 제1 실시예에 따른 플러싱 장치(700)를 보다 자세히 설명하면 다음과 같다.Hereinafter, with reference to FIGS. 2 to 4, the flushing apparatus 700 according to the first embodiment of the present disclosure will be described in more detail as follows.

플러싱 장치(700)는 내부에 소정의 유로(P)를 형성한다. 유로(P)는, 연결 관(300, 300')의 상류 측 말단과 환자 연결 모듈(600, 600')의 상류 측 말단을 연결하는 제1 유로(P1)를 포함한다. 제1 유로는 직선형으로 형성될 수 있다.The flushing apparatus 700 forms a predetermined flow path P therein. The flow path P includes a first flow path P1 connecting the upstream ends of the connection tubes 300 and 300 'and the upstream ends of the patient connection modules 600 and 600'. The first flow path may be formed in a straight line.

제1 유로(P1)는, 상기 연결 지점(P1F)을 기준으로 상류 측에 배치되는 상류 유로부(P1a)와 하류 측에 배치되는 하류 유로부(P1b)를 포함한다. 상류 유로부(P1a)는 제1 유로(P1)의 일 부분이다. 하류 유로부(P1b)는 제1 유로(P1)의 일부분이다. 상류 유로부(P1a)는, 제1 유로(P1)의 상류 측 말단으로부터 상기 연결 지점(P1F)까지 연결한다. 하류 유로부(P1b)는 상기 연결 지점(P1F)으로부터 제1 유로(P1)의 하류 측 말단까지 연결한다. 상류 유로부(P1a)는 하류 유로부(P1b)보다 길게 형성될 수 있다.The first flow path P1 includes an upstream flow path portion P1a disposed on the upstream side with respect to the connection point P1F and a downstream flow path portion P1b disposed on the downstream side. The upstream flow path portion P1a is a part of the first flow path P1. The downstream flow path portion P1b is a part of the first flow path P1. The upstream passage portion P1a connects from the upstream end of the first flow path P1 to the connection point P1F. The downstream flow path portion P1b connects from the connection point P1F to the downstream end of the first flow path P1. The upstream passage portion P1a may be formed longer than the downstream passage portion P1b.

유로(P)는, 제1 유로(P1)의 상기 연결 지점(P1F)에서 일단이 연결되는 제2 유로(P2)를 포함한다. 제2 유로(P2)는 상기 연결 지점(P1F)과 후술할 플러싱 포트(715a)를 연결한다. 제2 유로(P2)는 제1 유로(P1)로부터 멀어지는 방향으로 연장될 수 있다.The flow path P includes a second flow path P2 to which one end is connected at the connection point P1F of the first flow path P1. The second flow path P2 connects the connection point P1F with a flushing port 715a to be described later. The second flow path P2 may extend in a direction away from the first flow path P1.

제1 유로(P1)의 일 부분으로서 조절 유로(P1a1)가 구성된다. 상류 유로부(P1a)는 조절 유로(P1a1)를 포함한다. 조절 유로(P1a1)는 유속 저감부(760)에 의해 형성된다. 조절 유로(P1a1)는 내부를 흐르는 액체의 유속을 저감시키도록, 유체 저항을 상승시키는 기능을 수행한다. 조절 유로(P1a1)는 제1 유로(P1)의 다른 부분에 비해 상대적으로 단면적이 작다. As a part of the first flow path P1, the regulating flow path P1a1 is constituted. The upstream flow path portion P1a includes an adjustment flow path P1a1. The control flow path P1a1 is formed by the flow rate reducing section 760. [ The control flow path P1a1 performs a function of raising the fluid resistance so as to reduce the flow rate of the liquid flowing therein. The control flow path P1a1 is relatively small in cross-sectional area as compared with other portions of the first flow path P1.

제1 유로(P1)의 다른 일 부분으로서 연결 유로(P1a2)가 구성된다. 상류 유로부(P1a)는 연결 유로(P1a2)를 포함한다. 연결 유로(P1a2)는, 유속 저감부(760)의 하류 측 말단(P1E)으로부터 상기 연결 지점(P1F)까지 연결한다. 조절 유로(P1a1)의 하류 측 말단(P1E)은 연결 유로(P1a2)의 상류 측 말단이다. 연결 유로(P1a2)는 조인트 파트(710A)에 의해 형성된다.The connecting passage P1a2 is formed as another portion of the first flow path P1. The upstream flow path portion P1a includes a connection flow path P1a2. The connection passage P1a2 connects from the downstream end P1E of the flow rate reduction section 760 to the connection point P1F. The downstream end P1E of the regulating passage P1a1 is the upstream end of the connecting passage P1a2. The connecting passage P1a2 is formed by the joint part 710A.

제1 유로(P1)의 또 다른 일 부분으로서 유입 유로(P1a3)가 구성될 수 있다. 상류 유로부(P1a)는 유입 유로(P1a3)를 포함한다. 유입 유로(P1a3)는, 상류 포트(711a)로부터 상기 조절 유로(P1a1)의 상류 측 말단까지 연결한다. 유입 유로(P1a3)의 상류 측 말단은 상류 포트(711a)를 형성한다. 유입 유로(P1a3)는 커버 파트(710B)에 의해 형성될 수 있다. 도시되지는 않았으나, 다른 예로, 별도의 유입 유로(P1a3)없이, 조절 유로(P1a1)의 상류 측 말단이 상류 포트(711a)를 형성할 수도 있다.The inflow path P1a3 may be constituted as another part of the first flow path P1. The upstream passage portion P1a includes the inflow passage P1a3. The inflow path P1a3 is connected from the upstream port 711a to the upstream end of the control flow path P1a1. The upstream end of the inflow passage P1a3 forms the upstream port 711a. The inflow passage P1a3 may be formed by the cover part 710B. Although not shown, in another example, the upstream end of the regulating passage P1a1 may form the upstream port 711a without a separate inflow passage P1a3.

메인 바디(710)는 적어도 상기 연결 유로(P1a2)를 형성하는 조인트 파트(710A)를 포함한다. 조인트 파트(710A)는 하류 유로부(P1b)를 형성할 수 있다. 조인트 파트(710A)는 제2 유로(P2)의 적어도 일부를 형성할 수 있다. 조인트 파트(710A)는 상류부(711)의 일부를 형성한다.The main body 710 includes a joint part 710A forming at least the connection passage P1a2. The joint part 710A can form the downstream flow path portion P1b. The joint part 710A may form at least a part of the second flow path P2. The joint part 710A forms a part of the upstream part 711. [

조인트 파트(710A)는 일체로 형성된다. 조인트 파트(710A)는 하나의 부품이다. 예를 들어, 조인트 파트(710A)는 일체로 사출되어 형성된다. 조인트 파트(710A)는 파괴되지 않는 한 분리 불가능하게 형성된다. 이를 통해, 상기 플러싱 단계 이후 플러싱 장치(700)를 폐기 처분할 때 사용자가 실수로 조인트 파트(710A)를 분리하여 내부의 상기 위험 약액이 외부로 노출되는 위험 상황 발생 확률을 줄일 수 있다. 또한, 만약 조인트 파트(710A)가 조립이 되는 부분일 경우 불순물이 제1 유로(P1) 내로 유입될 수 있는데, 조인트 파트(710A)가 일체로 형성됨으로써 보다 위생적인 플러싱 장치(700)를 구현할 수 있다.The joint part 710A is integrally formed. The joint part 710A is a single part. For example, the joint part 710A is integrally formed by injection. The joint part 710A is formed not to be detachable unless it is broken. Accordingly, when the flushing apparatus 700 is discarded after the flushing step, the user may accidentally remove the joint part 710A, thereby reducing the risk of occurrence of a dangerous situation in which the dangerous chemical liquid in the inside is exposed to the outside. In addition, if the joint part 710A is a part to be assembled, the impurities can be introduced into the first flow path P1. Since the joint part 710A is integrally formed, a more hygienic flushing device 700 can be realized have.

상기 연결 유로(P1a2)는 상기 하류 유로부(P1b)보다 짧을 수 있다. 이를 통해, 일체로 형성된 조인트 파트(710A)의 재료비를 줄일 수 있다. 또한, 이를 통해, 상기 플러싱 단계에서 상기 연결 유로(P1a2)에 채워져 있는 상기 위험 약액의 양을 줄여, 위험 약액을 최대한 많이 환자에게 주입시키려는 경우에 있어서 불필요하게 낭비되는 위험 약액의 양을 줄일 수 있다.The connection passage P1a2 may be shorter than the downstream passage portion P1b. Thus, the material cost of the integrally formed joint part 710A can be reduced. In addition, by reducing the amount of the hazardous chemical solution filled in the connection passage P1a2 in the flushing step, the amount of the dangerous chemical solution unnecessarily wasted when injecting the dangerous chemical solution into the patient as much as possible can be reduced .

메인 바디(710)는, 조인트 파트(710A)에 결합되는 커버 파트(710B)를 포함한다. 커버 파트(710B)의 하류 측 부분이 조인트 파트(710A) 내로 삽입된다. 조인트 파트(710A) 및 커버 파트(710B) 중, 어느 하나는 다른 하나의 방향으로 돌출된 결합부(710A1)를 포함하고, 다른 하나는 결합부(710A1)가 걸림되는 결합 대응부(710B1)를 포함한다. 본 실시예에서, 조인트 파트(710A)에 후크 형의 결합부(710A1)가 형성되고, 커버 파트(710B)에 결합부(710A1)가 걸림되는 홈 형의 결합 대응부(710B1)가 형성된다.The main body 710 includes a cover part 710B coupled to the joint part 710A. The downstream portion of the cover part 710B is inserted into the joint part 710A. One of the joint part 710A and the cover part 710B includes a coupling part 710A1 protruding in the other direction and the other is a coupling corresponding part 710B1 in which the coupling part 710A1 is hooked . In this embodiment, a hook-shaped engaging portion 710A1 is formed in the joint part 710A and a groove-like engaging portion 710B1 is formed in which the engaging portion 710A1 is engaged with the cover part 710B.

커버 파트(710B)는 조인트 파트(710A)와 함께 유속 저감부(760)를 내부에 수용한다. 조인트 파트(710A)는 유속 저감부(760)의 하류 측 말단을 지지한다. 조인트 파트(710A)는 유속 저감부(760)의 하류 측 말단이 걸림되는 턱을 형성하는 제1 안착부(710A2)를 포함할 수 있다. 커버 파트(710B)는 유속 저감부(760)의 상류 측 말단을 지지한다. 커버 파트(710B)는 유속 저감부(760)의 상류 측 말단이 걸림되는 턱을 형성하는 제2 안착부(710B2)를 포함할 수 있다.The cover part 710B accommodates the flow rate reducing part 760 together with the joint part 710A. The joint part 710A supports the downstream end of the flow rate reduction part 760. [ The joint part 710A may include a first seating part 710A2 that forms a step where the downstream end of the flow rate reduction part 760 is hooked. The cover part 710B supports the upstream end of the flow rate reducing part 760. [ The cover part 710B may include a second seating part 710B2 that forms a step to which the upstream end of the flow rate reducing part 760 is caught.

커버 파트(710B)는 상류 포트(711a)를 형성한다. 커버 파트(710B)는 유입 유로(P1a3)를 형성할 수 있다. 커버 파트(710B)는 상류부(711)의 일부를 형성한다. 커버 파트(710B)는 일체로 형성된다.The cover part 710B forms the upstream port 711a. The cover part 710B can form the inflow passage P1a3. The cover part 710B forms a part of the upstream part 711. [ The cover part 710B is integrally formed.

상류부(711)는 제1 유로(P1) 중 상기 연결 지점(P1F)의 상류 측 부분을 형성한다. 상류부(711)는 조인트 파트(710A)와 커버 파트(710B)에 의해 형성된다. 상류부(711)는 연결 관(300, 300')으로부터 액체가 유입되는 상류 포트(711a)를 형성한다.The upstream portion 711 forms an upstream portion of the connection point P1F among the first flow paths P1. The upstream portion 711 is formed by the joint part 710A and the cover part 710B. The upstream portion 711 forms an upstream port 711a through which the liquid flows from the coupling tubes 300 and 300 '.

하류부(713)는 제1 유로(P1) 중 상기 연결 지점(P1F)의 하류 측 부분을 형성한다. 하류부(713)는 조인트 파트(710A)에 의해 형성된다. 하류부(713)는 제1 유로(P1)로부터 하류 측으로 액체가 유출되는 하류 포트(713a)를 형성한다.The downstream portion 713 forms a portion of the first flow path P1 downstream of the connection point P1F. The downstream portion 713 is formed by the joint part 710A. The downstream portion 713 forms a downstream port 713a through which the liquid flows from the first flow path P1 to the downstream side.

하류부(713)는, 교체 결합부(770)가 하류부(713)로부터 이탈되는 것을 막아주는 걸림부(713b)를 포함한다. 걸림부(713b)는 하류부(713)의 외표면에서 돌출되어 형성될 수 있다. 걸림부(713b)의 상류 측 방향 면이 교체 결합부(770)의 일부에 접촉되어, 교체 결합부(770)의 하류 측 방향으로의 이동 범위를 제한한다.The downstream portion 713 includes an engagement portion 713b that prevents the replacement engaging portion 770 from being detached from the downstream portion 713. [ The latching portion 713b may protrude from the outer surface of the downstream portion 713. [ The upstream side surface of the engaging portion 713b comes into contact with a part of the replacement engaging portion 770 to limit the range of movement of the replacement engaging portion 770 in the downstream direction.

플러싱부(715)는 제2 유로(P2)를 형성한다. 플러싱부(715)의 적어도 일부는 조인트 파트(710A)에 의해 형성된다. 플러싱부(715)는, 제2 유로(P2) 내로 플러싱용 액체를 유입시키기 위한 플러싱 포트(715a)를 형성한다.The flushing portion 715 forms the second flow path P2. At least a portion of the flushing portion 715 is formed by the joint part 710A. The flushing portion 715 forms a flushing port 715a for introducing the liquid for flushing into the second flow path P2.

유속 저감부(760)는, 제1 유로(P1) 내에 흐르는 상기 위험 약액의 유속을 저감하도록 구성된다. 다른 조건이 동일할 때 제1 유로(P1)를 흐르는 액체의 유속은, 유속 저감부(760)가 없는 가정된 상태의 상기 플러싱 장치에 비해, 유속 저감부(760)가 구성된 상태의 상기 플러싱 장치(700)에서 저감된다. 도시되지는 않았으나, 사용자에 의해 유속을 변경 조절 가능하게 구현된 상기 유속 저감부가 구현될 수도 있다.The flow rate reduction section 760 is configured to reduce the flow rate of the dangerous chemical liquid flowing in the first flow path P1. The flow rate of the liquid flowing through the first flow path P1 when the other conditions are the same is smaller than that of the flushing apparatus in the assumed state in which the flow rate reducing section 760 is not provided, (700). Although not shown, the flow rate reduction unit implemented by a user to change the flow rate may be implemented.

유속 저감부(760)는 제1 유로(P1)에서 연결 지점(P1F)보다 상류 측에 배치된다. 유속 저감부(760)의 하류 측 말단은 조인트 파트(710A)에 삽입된다. 유속 저감부(760)의 상류 측 말단은 커버 파트(710B)에 삽입된다.The flow rate reduction portion 760 is disposed on the upstream side of the connection point P1F in the first flow path P1. The downstream end of the flow rate reduction portion 760 is inserted into the joint part 710A. The upstream end of the flow rate reduction portion 760 is inserted into the cover part 710B.

본 실시예에서, 유속 저감부(760)는 상기 조절 유로(P1a1)를 형성하는 조절 유로 형성부(761)를 포함한다. 유속 저감부(760)는 조절 유로 형성부(761)의 외주면과 메인 바디(710)의 내주부 사이에 배치되는 실링부(762)를 포함한다. 유속 저감부(760)는 조절 유로 형성부(761)의 말단에 배치되는 스페이서(763)를 포함할 수 있다. 유속 저감부(760)는, 조절 유로 형성부(761)의 상류 측 말단과 제2 안착부(710B2) 사이에 배치되는 제1 스페이서(763a)를 포함할 수 있다. 유속 저감부(760)는 조절 유로 형성부(761)의 하류 측 말단과 제1 안착부(710A2) 사이에 배치되는 제2 스페이서(763b)를 포함할 수 있다. 도시되지는 않았으나, 유속 저감부(760)는 조절 유로(P1a1)의 상류 측 말단에 배치되는 필터부(미도시)를 더 포함할 수 있다.In this embodiment, the flow rate reduction unit 760 includes an adjustment flow path forming unit 761 for forming the adjustment flow path P1a1. The flow rate reducing portion 760 includes a sealing portion 762 disposed between the outer peripheral surface of the control flow path forming portion 761 and the inner peripheral portion of the main body 710. The flow rate reduction portion 760 may include a spacer 763 disposed at the end of the adjustment flow path forming portion 761. The flow rate reduction portion 760 may include a first spacer 763a disposed between the upstream end of the control flow path forming portion 761 and the second seating portion 710B2. The flow rate reduction portion 760 may include a second spacer 763b disposed between the downstream end of the control flow path forming portion 761 and the first seating portion 710A2. Although not shown, the flow rate reduction unit 760 may further include a filter unit (not shown) disposed at the upstream end of the control flow path P1a1.

교체 결합부(770)는 하류부(713)에 배치된다. 교체 결합부(770)는 환자 연결 모듈(600, 600')과 분리 가능하게 결합된다. 교체 결합부(770)는 후술할 하류 벤트 캡(780)과 분리 가능하게 결합될 수 있다.The replacement engaging portion 770 is disposed at the downstream portion 713. The replacement coupling portion 770 is detachably coupled to the patient connection module 600, 600 '. The replacement engaging portion 770 may be releasably coupled to the downstream vent cap 780, which will be described later.

교체 결합부(770)는 하류부(713)의 외주부를 둘러싸도록 형성될 수 있다. 교체 결합부(770)의 내주부는 하류부(713)의 외주부를 마주본다.The replacement engaging portion 770 may be formed so as to surround the outer peripheral portion of the downstream portion 713. The inner circumferential portion of the replacement engaging portion 770 faces the outer circumferential portion of the downstream portion 713.

교체 결합부(770)는 환자 연결 모듈(600, 600')과 결합을 위한 스크류 대응부(771)를 포함할 수 있다. 스크류 대응부(771)는 상기 하류 벤트 캡(780)과 결합 가능하도록 구성될 수 있다. 스크류 대응부(771)는 교체 결합부(770)의 내주부에 배치될 수 있다.The replacement engaging portion 770 may include a screw corresponding portion 771 for engaging with the patient connecting module 600, 600 '. The screw corresponding portion 771 may be configured to be coupled to the downstream vent cap 780. The screw corresponding portion 771 may be disposed at the inner circumferential portion of the replaceable engaging portion 770.

교체 결합부(770)는 상기 걸림부(713b)에 걸림되도록 구성된 걸림 대응부(772)를 포함할 수 있다. 걸림 대응부(772)는 교체 결합부(770)의 상류 측에 배치될 수 있다. 걸림 대응부(772)는 교체 결합부(770)의 내주부에서 하류부(713)의 외주부를 향해 돌출된다.The replaceable engaging portion 770 may include an engaging portion 772 configured to engage with the engaging portion 713b. The engaging portion 772 may be disposed on the upstream side of the replaceable engaging portion 770. The engaging portion 772 protrudes from the inner peripheral portion of the replacement engaging portion 770 toward the outer peripheral portion of the downstream portion 713. [

역류 방지부(750)는, 제2 유로(P2) 내에서 상기 플러싱용 액체의 상기 플러싱 포트 방향으로의 역류를 방지한다. 역류 방지부(750)는 체크 밸브(one-way valve)의 기능을 수행한다. 역류 방지부(750)는, 제2 유로(P2) 내로부터 제1 유로(P1) 내로 이동하는 액체의 흐름(유입 흐름)을 허용하되, 제1 유로(P1) 내로부터 제2 유로(P2) 내로 이동하는 액체의 흐름(유출 흐름)을 막는다.The backflow prevention portion 750 prevents the backflow of the flushing liquid in the direction of the flushing port in the second flow path P2. The backflow prevention part 750 functions as a one-way valve. The backflow prevention portion 750 permits the flow of liquid (inflow flow) that moves from the inside of the second flow path P2 into the first flow path P1, while allowing the flow of the liquid from the inside of the first flow path P1 to the second flow path P2, Thereby blocking the flow of the liquid (flow-out)

일 예로, 플러싱 밸브 유닛(720)이 플러싱부(715)로부터 분리된 상태에서, 역류 방지부(750)는 플러싱부(715)에 결합 및 분리가 가능하게 구현될 수 있다. 다른 예로, 역류 방지부(750)는 플러싱 밸브 유닛(720)에 결합되어, 플러싱 밸브 유닛(720)이 플러싱부(715)로부터 분리 시 역류 방지부(750)가 플러싱 밸브 유닛(720)과 함께 플러싱부(715)로부터 분리되게 구현될 수도 있다.For example, in a state where the flushing valve unit 720 is separated from the flushing part 715, the backflow prevention part 750 can be implemented to be coupled to and detachable from the flushing part 715. The backflow prevention portion 750 is coupled to the flushing valve unit 720 so that the backflow prevention portion 750 is separated from the flushing portion 715 when the flushing valve unit 720 is separated from the flushing portion 715, And may be implemented to be separated from the flushing portion 715.

역류 방지부(750)는 상기 유입 흐름의 방향(F5)으로 돌출된 돌출부(751)를 포함한다. 돌출부(751)는 플렉서블한 재질로 형성된다.The backflow prevention portion 750 includes a protrusion 751 protruding in the direction F5 of the inflow flow. The protrusion 751 is formed of a flexible material.

돌출부(751)의 돌출 말단에 홀(751a)이 형성된다. 상기 홀(751a)은 상기 플러싱용 액체가 통과하기 위해 형성된다. 상기 홀(751a)은 제2 유로(P2) 내의 액체의 흐름 방향에 따라 개폐 여부가 달라진다. 제2 유로(P2) 내의 액체가 상기 유입 흐름의 방향(F5)으로 흐를 때 돌출부(751)의 상기 홀(751a)이 열린다. (도 3 참고) 제2 유로(P2) 내의 액체의 흐름이 없거나 액체가 상기 유출 흐름 방향(F6)으로 흐르려 할 때 돌출부(751)의 상기 홀(751a)이 닫힌다.A hole 751a is formed at the protruding end of the protrusion 751. The hole 751a is formed for the flushing liquid to pass through. The hole 751a is opened or closed according to the flow direction of the liquid in the second flow path P2. The hole 751a of the protrusion 751 is opened when the liquid in the second flow path P2 flows in the direction of the inflow flow F5. (See FIG. 3), the hole 751a of the protrusion 751 is closed when there is no flow of the liquid in the second flow path P2 or when the liquid is going to flow in the outflow direction F6.

역류 방지부(750)는 플러싱부(715)에 안착되는 안착부(753)를 포함한다. 안착부(753)는 플러싱 포트(715a)의 가장자리 부분에 안착될 수 있다. 안착부(753)는 돌출부(751)를 지지한다. 안착부(753)의 중심은 홀을 형성하고, 안착부(753)의 홀을 통해 액체가 돌출부(751)의 상기 홀(751a)로 이동할 수 있다.The backflow prevention portion 750 includes a seat portion 753 that is seated on the flushing portion 715. The seat portion 753 can be seated in the edge portion of the flushing port 715a. The seating portion 753 supports the projection 751. The center of the seating portion 753 forms a hole and the liquid can move to the hole 751a of the projection 751 through the hole of the seating portion 753. [

일 예로, 돌출부(751)는 전체적으로 원뿔형으로 형성되어 꼭지점 부분이 돌출되게 형성될 수 있다. 이 경우, 돌출부(751)의 상기 꼭지점 부분에 상기 홀(751a)이 형성된다.For example, the protrusion 751 may be formed in a conical shape as a whole, so that the vertex portion protrudes. In this case, the hole 751a is formed in the vertex portion of the protrusion 751.

다른 예로, 돌출부(751)는, 돌출 방향에 대해 기울어지며 연장되는 제1 빗면과, 돌출 방향에 대해 상기 제1 빗면과 반대 방향으로 기울어지며 연장되는 제2 빗면과, 상기 제1 빗면 및 제2 빗면의 양 측방을 덮어주는 양 측면을 포함한다. (도 6 및 도 9 참고) 이 경우, 상기 제1 빗면과 상기 제2 빗면은 돌출부(751)의 돌출 말단에서 모서리를 형성하며 만나고, 상기 모서리를 따라 상기 홀(751a)이 길게 연장되며 형성된다. 제2 유로(P2) 내의 액체가 상기 유입 흐름의 방향(F5)으로 흐를 때, 상기 제1 빗면의 돌출 말단과 상기 제2 빗면의 돌출 말단이 서로 반대 방향으로 휘어지면서, 상기 홀(751a)이 열린다.As another example, the protruding portion 751 may include a first oblique surface that inclines and extends with respect to the protruding direction, a second oblique surface that inclines and extends in a direction opposite to the first oblique direction with respect to the protruding direction, And both side surfaces covering both sides of the oblique side. 6 and 9). In this case, the first oblique face and the second oblique face meet at the protruding end of the protruding portion 751, and the hole 751a extends along the edge . When the liquid in the second flow path P2 flows in the direction of the inflow flow F5, the protruding end of the first oblique surface and the protruding end of the second oblique surface are bent in directions opposite to each other, It opens.

플러싱 밸브 유닛(720)은 플러싱부(715)에 결합된다. 플러싱 밸브 유닛(720)은 플러싱 포트(715a)에 추가로 결합될 수 있다. 상기 플러싱용 액체는, 외부로부터 플러싱 밸브 유닛(720) 및 플러싱 포트(715a)를 순차적으로 거쳐 제2 유로(P2) 내로 유입될 수 있다.The flushing valve unit 720 is coupled to the flushing portion 715. The flushing valve unit 720 may be further coupled to the flushing port 715a. The flushing liquid may flow into the second flow path P2 sequentially from the outside through the flushing valve unit 720 and the flushing port 715a.

플러싱 밸브 유닛(720)은 상기 플러싱용 액체의 통로 개폐 여부를 변경하는 플러싱 밸브(722)를 포함한다. 플러싱 밸브 유닛(720)은 플러싱 밸브(722)를 지지하는 밸브 케이싱(721)을 포함한다. 플러싱 밸브 유닛(720)은 스웨버블 밸브(swabable valve)를 포함할 수 있다.The flushing valve unit 720 includes a flushing valve 722 for changing whether the flushing liquid is opened or closed. The flushing valve unit 720 includes a valve casing 721 that supports the flushing valve 722. [ The flushing valve unit 720 may include a swabable valve.

플러싱 밸브(722)는, 외부로부터 누름시 개방되는 홀(722h)을 형성하는 표면(722a)을 포함한다. (도 3 참고) 플러싱 밸브(722)는 플렉서블한 재질로 형성된다. 표면(722a)에 외부로부터 주사기(J)의 팁이 가압된 경우, 표면(722a)이 휘어지며 홀(722h)이 열린다.The flushing valve 722 includes a surface 722a that forms a hole 722h that is opened when pressed from the outside. 3). The flushing valve 722 is formed of a flexible material. When the tip of the syringe J is pressed against the surface 722a from the outside, the surface 722a is bent and the hole 722h is opened.

플러싱 포트 개폐부(740)는 상기 표면(722a)을 외부로부터 개폐시킨다. 플러싱 포트 개폐부(740)는 플러싱 밸브 유닛(720)과 결합된 상태에서 상기 표면(722a)을 덮어준다. 플러싱 포트 개폐부(740)이 플러싱 밸브 유닛(720)과 분리된 상태에서, 상기 표면(722a)이 외부로 노출된다. 상기 표면(722a)이 외부로 노출된 상태에서, 사용자가 상기 표면(722a)을 닦을 수 있다. 실시예에 따라서는, 플러싱 포트 개폐부(740)는 플러싱 밸브 유닛(720)과 결합된 상태에서 상기 표면(722a)을 소독해주는 기능을 가질 수 있다.The flushing port opening / closing part 740 opens / closes the surface 722a from outside. The flushing port opening and closing part 740 covers the surface 722a in a state of being engaged with the flushing valve unit 720. [ The surface 722a is exposed to the outside in a state where the flushing port opening and closing part 740 is separated from the flushing valve unit 720. [ With the surface 722a exposed to the outside, the user can clean the surface 722a. According to an embodiment, the flushing port opening and closing part 740 may have a function of disinfecting the surface 722a while being coupled with the flushing valve unit 720. [

플러싱 밸브(722)는 일 측에 상기 표면(722a)을 형성하는 노출부(722b)를 포함한다. 상기 홀(722h)은 노출부(722b)를 관통한다. 외부로부터 노출부(722b)를 통과하며 유입된 상기 플러싱용 액체는 플러싱 포트(715a)로 이동할 수 있다.The flushing valve 722 includes an exposed portion 722b which forms the surface 722a on one side. The hole 722h penetrates through the exposed portion 722b. The flushing liquid that has passed through the exposed portion 722b from the outside can be moved to the flushing port 715a.

플러싱 밸브(722)는 노출부(722b)를 지지하는 관부(722c)를 포함한다. 관부(722c)는 내부 공간을 형성하며 관 형으로 형성된다. 관부(722c)의 일단에 노출부(722b)의 둘레가 고정되고, 타단은 중앙의 오프닝(opening)의 경계를 형성한다.The flushing valve 722 includes a tube portion 722c that supports the exposed portion 722b. The tube portion 722c forms an inner space and is formed in a tubular shape. The periphery of the exposed portion 722b is fixed to one end of the tube portion 722c, and the other end forms a boundary of the opening at the center.

밸브 케이싱(721)은 플러싱 밸브(722)를 내부에 수용한다. 밸브 케이싱(721)은 일 단에 상기 표면(722a)을 노출 시키기 위한 개구부를 형성한다. 밸브 케이싱(721)의 타단은 플러싱부(715)에 결합된다. 밸브 케이싱(721)은 플러싱부(715)에 결합되는 유닛 결합부(721b)를 포함한다.The valve casing 721 receives the flushing valve 722 therein. The valve casing 721 forms an opening for exposing the surface 722a at one end. The other end of the valve casing 721 is coupled to the flushing portion 715. The valve casing 721 includes a unit engaging portion 721b which is engaged with the flushing portion 715.

밸브 케이싱(721)은 플러싱부(715)와 결합 상태에서 역류 방지부(750)를 고정하는 누름부(721a)를 포함한다. 누름부(721a)는 안착부(753)를 눌러준다. 안착부(753)는 누름부(721a)와 플러싱부(715) 사이에 끼여 고정된다.The valve casing 721 includes a pressing portion 721a for fixing the backflow prevention portion 750 in a state of being engaged with the flushing portion 715. The pressing portion 721a presses the seating portion 753. The seat portion 753 is held between the pressing portion 721a and the flushing portion 715 and fixed.

하류 벤트 캡(780)은 교체 결합부(770)에 환자 연결 모듈(600, 600') 대신 분리 가능하게 결합된다. 하류 벤트 캡(780)은 상기 프라이밍 단계의 시작 전 교체 결합부(770)에 결합된다. 상기 약액 주입 단계 전 하류 벤트 캡(780)은 교체 결합부(770)로부터 분리될 수 있다. 도 1a 내지 도 3에서만 하류 벤트 캡(780)을 도시하고, 다른 도면 들에서는 중복 내용을 피하기 위해 하류 벤트 캡(780)의 도시를 생략한다.The downstream vent cap 780 is detachably coupled to the replaceable engagement portion 770 instead of the patient connection module 600, 600 '. The downstream vent cap 780 is coupled to the replacement engagement portion 770 before the start of the priming step. The downstream vent cap 780 before the chemical liquid injection step can be separated from the replacement engagement portion 770. Only the downstream vent cap 780 is shown in FIGS. 1A-3, and the illustration of the downstream vent cap 780 is omitted in the other figures to avoid redundancy.

하류 벤트 캡(780)은, 제1 유로(P1) 내에서 상기 프라이밍용 액체가 연결 지점(P1F)으로부터 하류부(713)를 따라 흐를 때, 기체를 배출시키되 상기 프라이밍용 액체의 배출을 차단한다.The downstream vent cap 780 discharges the gas and blocks the discharge of the priming liquid when the priming liquid flows along the downstream portion 713 from the connection point P1F in the first flow path P1.

하류 벤트 캡(780)은 상기 프라이밍용 액체의 통과를 막되 기체의 통과를 허용하는 벤트 필터(781)를 포함한다. 벤트 필터(781)는 소수성 필터를 포함할 수 있다.The downstream vent cap 780 includes a vent filter 781 that prevents passage of the priming liquid and allows passage of gas. Vent filter 781 may comprise a hydrophobic filter.

하류 벤트 캡(780)은 벤트 필터(781)의 상류 측에 배치되는 스펀지(782)를 포함할 수 있다. 스펀지(782)의 하류 측 말단은 벤트 필터(781)에 접촉된다. 스펀지(782)는 상기 프라이밍용 액체를 흡수하면서 기체의 통과를 돕는다.The downstream vent cap 780 may include a sponge 782 disposed upstream of the vent filter 781. The downstream end of the sponge 782 is in contact with the vent filter 781. The sponge 782 assists in passing the gas while absorbing the priming liquid.

하류 벤트 캡(780)은 벤트 필터(781)를 내부에 수용하는 하류 벤트 케이싱(783)을 포함한다. 하류 벤트 케이싱(783)은 스펀지(782)를 내부에 수용한다. 하류 벤트 케이싱(783)은 기체가 통과하는 벤트 홀(783a)을 형성한다. 벤트 홀(783a)은 벤트 필터(781)의 하류 측에 배치된다. 제1 유로(P1) 내의 기체는 순차적으로 스펀지(782), 벤트 필터(781) 및 벤트 홀(783a)을 거쳐, 제1 유로(P1) 밖으로 유출된다.The downstream vent cap 780 includes a downstream vent casing 783 that receives the vent filter 781 therein. The downstream vent casing 783 receives the sponge 782 therein. The downstream vent casing 783 forms a vent hole 783a through which the gas passes. The vent hole 783a is disposed on the downstream side of the vent filter 781. [ The gas in the first flow path P1 flows out of the first flow path P1 sequentially through the sponge 782, the vent filter 781 and the vent hole 783a.

하류 벤트 캡(780)은 교체 결합부(770)와 결합되는 하류 벤트 캡 결합부(784)를 포함한다. 하류 벤트 캡 결합부(784)는 원통 형으로 형성될 수 있다. 하류 벤트 캡 결합부(784)는 하류 벤트 케이싱(783)의 상류 측에 연결된다.The downstream vent cap 780 includes a downstream vent cap engaging portion 784 coupled with the replaceable engagement portion 770. The downstream vent cap coupling portion 784 may be formed in a cylindrical shape. The downstream vent cap engaging portion 784 is connected to the upstream side of the downstream vent casing 783.

하류 벤트 캡 결합부(784)의 외주부에 스크류(785)가 형성될 수 있다. 스크류(785)는 교체 결합부(770)의 스크류 대응부(771)에 맞물리도록 형성된다.A screw 785 may be formed on the outer peripheral portion of the downstream vent cap coupling portion 784. The screw 785 is formed to engage with the screw corresponding portion 771 of the replacement engaging portion 770.

도 2 내지 도 4를 참고하여 상술한 제1 실시예에 따른 플러싱 장치(700)에 대한 설명은, 도 5 내지 도 11을 참고하여 후술할 제2 내지 제5 실시예에 따른 플러싱 장치(700', 700'', 700''', 700'''')에도 적용된다.The description of the flushing apparatus 700 according to the first embodiment described above with reference to Figs. 2 to 4 will be given to flushing apparatus 700 'according to the second to fifth embodiments described later with reference to Figs. 5 to 11, , 700 '', 700 '' ', 700' '' ').

또한, 도 2 내지 도 4를 참고하여, 제1 실시예에 따른 플러싱 장치(700)는 제1 유로(P1)에 대해, 예를 들어 예각을 이루며 연장되는 제2 유로(P2)를 형성하는 플러싱부(715)를 포함한다. 제2 유로(P2)는, 연결 지점(P1F)으로부터 제1 유로(P1)의 하류 방향과 제1 유로(P1)의 수직 방향의 사이 방향으로 연장된다.2 to 4, the flushing apparatus 700 according to the first embodiment is a flushing apparatus that forms a second flow path P2, for example, at an acute angle with respect to the first flow path P1, (715). The second flow path P2 extends from the connection point P1F in the direction between the downstream direction of the first flow path P1 and the direction perpendicular to the first flow path P1.

제1 실시예에서, 플러싱부(715)는, 제2 유로(P2)과 제1 유로(P1)에 연결되는 부분을 형성하는 플러싱 조인트부(715b)를 포함한다. 플러싱 조인트부(715b)는 조인트 파트(710A)에 의해 형성된다. 플러싱부(715)는 상기 플러싱 포트(715a)를 형성한다. 플러싱부(715)는 플러싱 포트(715a)의 주위에서 플러싱 밸브 유닛(720)이 결합되는 플러싱 안착부(715c)를 포함한다. 유닛 결합부(721b)와 플러싱 안착부(715c)가 서로 결합될 수 있다. 플러싱 포트(715a)에 상기 역류 방지부(750)가 배치될 수 있다.In the first embodiment, the flushing portion 715 includes a flushing joint portion 715b that forms a portion connected to the second flow path P2 and the first flow path P1. The flushing joint portion 715b is formed by the joint part 710A. The flushing portion 715 forms the flushing port 715a. The flushing portion 715 includes a flushing seat portion 715c to which the flushing valve unit 720 is coupled around the flushing port 715a. The unit coupling portion 721b and the flushing seat portion 715c can be coupled to each other. And the backflow prevention part 750 may be disposed in the flushing port 715a.

이하, 도 5 및 도 6을 참고하여, 제1 실시예와의 차이점을 중심으로, 제2 실시예에 따른 플러싱 장치(700')를 설명하면 다음과 같다. 제2 실시예에서, 플러싱부(715)는 플렉서블한 재질의 연장 관(715d)을 더 포함한다. 플러싱부(715)는, 제1 유로(P1)의 하류 방향과 제1 유로(P1)의 수직 방향의 사이 방향으로 연장되는 제2 유로(P2)의 일 부분을 형성하는 플러싱 조인트부(715b)를 포함한다. 연장 관(715d)은 플러싱 조인트부(715b)와 플러싱 포트(715a)를 연결한다. 연장 관(715d)은 제2 유로(P2)의 일 부분을 형성한다. 상기 플러싱용 액체는, 외부로부터 순차적으로 플러싱 포트(715a), 연장관(715d) 및 플러싱 조인트부(715b)를 거쳐 제1 유로(P1) 내로 유입된다. 사용자가 상기 플러싱용 액체를 주입할 때 자세에 따라 자유롭게 연장 관(715d)을 휘어지게 할 수 있어, 편리하다.Referring to FIGS. 5 and 6, a flushing apparatus 700 'according to a second embodiment will now be described, focusing on differences from the first embodiment. In the second embodiment, the flushing portion 715 further includes an extension pipe 715d made of a flexible material. The flushing portion 715 includes a flushing joint portion 715b that forms a part of the second flow path P2 extending in the direction between the downstream direction of the first flow path P1 and the vertical direction of the first flow path P1, . The extension pipe 715d connects the flushing joint portion 715b and the flushing port 715a. The extension pipe 715d forms a part of the second flow path P2. The flushing liquid flows into the first flow path P1 sequentially from the outside through the flushing port 715a, the extension pipe 715d and the flushing joint portion 715b. It is possible to freely flex the extension pipe 715d according to the posture when the user injects the flushing liquid, which is convenient.

이하, 도 7 내지 도 9를 참고하여, 제1 실시예와의 차이점을 중심으로, 제3 실시예에 따른 플러싱 장치(700'')를 설명하면 다음과 같다. 상기 제3 실시예에 따른 플러싱 장치(700'')는, 제1 유로(P1)와 수직을 이루는 제2 유로(P2)를 형성하는 플러싱부(715)를 포함한다. 제2 유로(P2)는, 연결 지점(P1F)으로부터 제1 유로(P1)의 수직 방향으로 연장될 수 있다.Hereinafter, the flushing apparatus 700 '' according to the third embodiment will be described with reference to FIGS. 7 to 9, focusing on differences from the first embodiment. The flushing apparatus 700 "according to the third embodiment includes a flushing unit 715 forming a second flow path P2 perpendicular to the first flow path P1. The second flow path P2 can extend from the connection point P1F in the vertical direction of the first flow path P1.

상기 제3 실시예에서, 역류 방지부(750)의 적어도 일부는 상기 연결 지점(P1F)에 배치된다. 역류 방지부(750)의 돌출부(751)는 제2 유로(P2)로부터 제1 유로(P1) 내로 돌출된다. 돌출부(751)의 홀(751h)은 제1 유로(P1) 내에 배치된다. 제2 유로(P2) 내의 상기 유입 흐름의 방향에 있어서, 제2 유로(P2)의 하류 측 말단에 역류 방지부(750)가 배치된다. 제2 유로(P2) 중 역류 방지부(750)를 기준으로 하류 측 부분이 없다. 이를 통해, 상기 프라이밍 단계에서 연결 관(300, 300')으로부터 제1 유로(P1)로 유입되는 상기 프라이밍용 액체가 제1 유로(P1)를 채우면, 별도로 제2 유로(P2) 내의 기포를 제거하는 프라이밍 단계 내 작업이 불필요한 바, 의료진에게 편리하다. 왜냐하면, 제2 유로(P2) 중 역류 방지부(750)를 기준으로 하류 측 부분이 없고, 제2 유로(P2) 중 역류 방지부(750)를 기준으로 상류 측 부분에는 공기가 있더라도 역류 방지부에 의해 공기가 제1 유로(P1) 내로 유입되지 않기 때문이다.In the third embodiment, at least a part of the backflow prevention part 750 is disposed at the connection point P1F. The protrusion 751 of the backflow prevention portion 750 protrudes into the first flow path P1 from the second flow path P2. The hole 751h of the protrusion 751 is disposed in the first flow path P1. In the direction of the inflow flow in the second flow path P2, the backflow prevention part 750 is disposed at the downstream end of the second flow path P2. There is no downstream portion with respect to the backflow prevention portion 750 of the second flow path P2. Accordingly, when the priming liquid flowing into the first flow path P1 from the connection pipe 300 or 300 'in the priming step fills the first flow path P1, bubbles in the second flow path P2 are separately removed It is convenient for the medical staff because the operation within the priming step is unnecessary. This is because there is no downstream portion of the second flow path P2 on the basis of the backflow prevention portion 750 and the airflow in the upstream portion of the second flow path P2 with respect to the backflow prevention portion 750, The air does not flow into the first flow path P1.

도 7 내지 도 9를 참고하여 상술한 제3 실시예에 따른 플러싱 장치(700'')에 대한 설명은, 도 10을 참고하여 후술할 제4 실시예에 따른 플러싱 장치(700''')에도 적용된다.The description of the flushing apparatus 700 '' according to the third embodiment described above with reference to Figs. 7 to 9 is also applicable to the flushing apparatus 700 '' 'according to the fourth embodiment to be described later with reference to Fig. 10 .

이하, 도 10을 참고하여, 제3 실시예와의 차이점을 중심으로, 제4 실시예에 따른 플러싱 장치(700''')를 더 설명하면 다음과 같다. 상기 제4 실시예에 따른 플러싱 장치(700''')는 플러싱 밸브 유닛(720)과의 결합없이 플러싱 포트 개폐부(740)와 결합 가능하게 구성된 플러싱부(715''')를 포함한다. 제4 실시예에 따른 플러싱 포트 개폐부(740)는 상기 표면(722a)을 소독해주는 기능을 가질 필요가 없다. 플러싱부(715''')는 조인트 파트(710A)에 결합되는 플러싱 결합부(715g''')를 포함할 수 있다. 플러싱부(715''')는 역류 방지부(750)의 안착부(753)를 눌러주어 고정하는 누름부(715f''')를 포함한다. 플러싱부(715''')는 플러싱 포트 개폐부(740)와 분리 가능하게 결합되는 개폐 결합부(715h''')를 포함한다. 개폐 결합부(715h''')는 내부에 제2 유로(P2)와 연결되는 통로를 형성한다. 상기 플러싱용 액체의 유입 흐름의 방향을 기준으로, 개폐 결합부(715h''')의 상류 측 말단에 플러싱 포트(715a)가 형성된다. 플러싱부(715)의 하류 측 말단에 역류 방지부(750)가 배치된다. 플러싱 포트 개폐부(740)는 플러싱부(715)에 결합 또는 분리됨으로써 플러싱 포트(715a)를 개폐시킨다.Hereinafter, with reference to FIG. 10, the flushing apparatus 700 '' 'according to the fourth embodiment will be further described, focusing on differences from the third embodiment. The flushing apparatus 700 '' 'according to the fourth embodiment includes a flushing unit 715' '' configured to be able to engage with the flushing port opening / closing unit 740 without engaging with the flushing valve unit 720. The flushing port opening / closing part 740 according to the fourth embodiment need not have a function of disinfecting the surface 722a. The flushing portion 715 '' 'may include a flushing engagement portion 715g' '' coupled to the joint portion 710A. The flushing portion 715 '' 'includes a pressing portion 715f' '' for pressing and fixing the seating portion 753 of the backflow prevention portion 750. The flushing portion 715 '' 'includes an opening / closing portion 715h' '' which is detachably coupled to the flushing port opening / closing portion 740. The open / close coupling portion 715h '' 'forms a passage which is connected to the second flow path P2. A flushing port 715a is formed at the upstream end of the opening / closing part 715h '' 'with reference to the direction of the flow of the flushing liquid. The backflow prevention portion 750 is disposed at the downstream end of the flushing portion 715. The flushing port opening / closing part 740 is coupled to or separated from the flushing part 715 to open / close the flushing port 715a.

이하, 도 11을 참고하여, 제1 실시예와의 차이점을 중심으로, 제5 실시예에 따른 플러싱 장치(700'''')를 설명하면 다음과 같다. 상기 제5 실시예에 따른 플러싱 장치(700'''')는 플러싱부(715)에 분리 가능하게 결합되는 플러싱 벤트 캡(730)을 더 포함한다. 플러싱 밸브 유닛(720)은 플러싱 벤트 캡(730)과 교체 가능하게 플러싱부(715)에 결합되도록 구성될 수 있다. 플러싱 벤트 캡(730)은 상기 프라이밍 단계의 시작 전 플러싱부(715)에 결합된다. 이 때, 플러싱부(715)에는 플러싱 밸브 유닛(720)과 역류 방지부(750)가 결합되지 않은 상태에서, 플러싱부(715)에 플러싱 벤트 캡(730)이 결합된다. 상기 약액 주입 단계 전 플러싱 벤트 캡(730)은 플러싱부(715)에 분리되고, 플러싱 밸브 유닛(720)이 플러싱부(715)에 결합될 수 있다.Hereinafter, referring to Fig. 11, a flushing apparatus 700 '' '' according to the fifth embodiment will be described, focusing on differences from the first embodiment. The flushing apparatus 700 '' '' according to the fifth embodiment further includes a flushing vent cap 730 detachably coupled to the flushing unit 715. The flushing valve unit 720 may be configured to be coupled to the flushing portion 715 to be replaceable with the flushing vent cap 730. The flushing vent cap 730 is coupled to the flushing portion 715 before the start of the priming step. At this time, the flushing vent cap 730 is coupled to the flushing part 715 in a state where the flushing valve unit 720 and the backflow prevention part 750 are not coupled to the flushing part 715. The flushing vent cap 730 may be separated from the flushing portion 715 and the flushing valve unit 720 may be coupled to the flushing portion 715. [

플러싱 벤트 캡(730)은, 제2 유로(P2) 내에 프라이밍용 액체가 상기 플러싱 포트 방향으로 흐름 시, 기체를 배출시키되 상기 프라이밍용 액체의 배출을 차단한다. 플러싱 벤트 캡(730)은 상기 프라이밍용 액체의 통과를 막되 기체의 통과를 허용하는 벤트 필터(731)를 포함한다. 벤트 필터(731)는 소수성 필터를 포함할 수 있다.When the priming liquid flows in the direction of the flushing port in the second flow path P2, the flushing vent cap 730 discharges the gas and blocks the discharge of the priming liquid. The flushing vent cap 730 includes a vent filter 731 that blocks the passage of the priming liquid and allows passage of gas. The vent filter 731 may comprise a hydrophobic filter.

하류 벤트 캡(780)은 벤트 필터(731)의 상류 측에 배치되는 스펀지(732)를 포함할 수 있다. 스펀지(732)의 하류 측 말단은 벤트 필터(731)에 접촉된다. 스펀지(732)는 상기 프라이밍용 액체를 흡수하면서 기체의 통과를 돕는다.The downstream vent cap 780 may include a sponge 732 disposed upstream of the vent filter 731. The downstream end of the sponge 732 is in contact with the vent filter 731. Sponge 732 assists passage of gas while absorbing the priming liquid.

하류 벤트 캡(780)은 벤트 필터(731)를 내부에 수용하는 플러싱 벤트 케이싱(733)을 포함한다. 플러싱 벤트 케이싱(733)은 스펀지(732)를 내부에 수용한다. 플러싱 벤트 케이싱(733)은 기체가 통과하는 벤트 홀(733a)을 형성한다. 벤트 홀(733a)은 벤트 필터(731)의 하류 측에 배치된다. 제2 유로(P2) 내의 기체는 순차적으로 스펀지(732), 벤트 필터(731) 및 벤트 홀(733a)을 거쳐, 제2 유로(P2) 밖으로 유출된다.The downstream vent cap 780 includes a flushing vent casing 733 for receiving a vent filter 731 therein. The flushing vent casing 733 receives the sponge 732 therein. The flushing vent casing 733 forms a vent hole 733a through which the gas passes. The vent hole 733a is disposed on the downstream side of the vent filter 731. [ The gas in the second flow path P2 sequentially flows out of the second flow path P2 via the sponge 732, the vent filter 731 and the vent hole 733a.

또한, 하류 벤트 캡(780)은 플러싱부(715)와 결합되는 플러싱 벤트 캡 결합부(734)를 포함한다. 플러싱 벤트 캡 결합부(734)는 원통 형으로 형성될 수 있다. 플러싱 벤트 캡 결합부(734)는, 상기 플러싱용 액체의 상기 유입 흐름의 방향을 기준으로 플러싱 벤트 케이싱(733)의 하류 측에 연결된다. 플러싱 벤트 캡 결합부(734)에 스크류(미도시)가 형성될 수 있다. 플러싱 벤트 캡(730)의 상기 스크류는 플러싱부(715)의 대응 부분에 맞물리도록 형성된다.The downstream vent cap 780 also includes a flushing vent cap engagement portion 734 coupled with the flushing portion 715. The flushing vent cap engaging portion 734 may be formed in a cylindrical shape. The flushing vent cap coupling portion 734 is connected to the downstream side of the flushing vent casing 733 based on the direction of the inflow flow of the flushing liquid. A screw (not shown) may be formed in the flushing vent cap engaging portion 734. The screw of the flushing cap cap 730 is formed to engage with the corresponding portion of the flushing portion 715.

이상 일부 실시예들과 첨부된 도면에 도시된 예에 의해 본 개시의 기술적 사상이 설명되었지만, 본 개시가 속하는 기술 분야에서 통상의 지식을 가진 자가 이해할 수 있는 본 개시의 기술적 사상 및 범위를 벗어나지 않는 범위에서 다양한 치환, 변형 및 변경이 이루어질 수 있다는 점을 알아야 할 것이다. 또한, 그러한 치환, 변형 및 변경은 첨부된 청구범위 내에 속하는 것으로 생각되어야 한다.Although the technical idea of the present disclosure has been described above by way of some embodiments and examples shown in the accompanying drawings, it is to be understood that the present invention is not limited to the above- It should be understood that various substitutions, changes, and alterations can be made therein without departing from the scope of the invention. It is also to be understood that such substitutions, modifications and variations are intended to be included within the scope of the appended claims.

Claims (15)

외부 공기에 노출 시 인체에 유해한 위험 약액을 안내하기 위한 연결 관과 상기 위험 약액을 환자에게 주입하기 위한 환자 연결 모듈을 연결하도록 구성되고, 상기 연결 관으로부터 상기 환자 연결 모듈로 상기 위험 약액을 안내하는 제1 유로를 형성하고, 상기 제1 유로의 양단 사이에 위치하는 소정의 연결 지점에 연결되는 제2 유로를 형성하는 플러싱부를 구비하는 메인 바디; 및A connection pipe for guiding the hazardous chemical solution harmful to the human body when exposed to the outside air and a patient connection module for injecting the dangerous chemical into the patient are connected to the patient connection module, A main body having a flushing portion forming a first flow path and forming a second flow path connected to a predetermined connection point located between both ends of the first flow path; And 상기 제1 유로에서 상기 연결 지점보다 상류 측에 배치되고, 상기 제1 유로 내에 흐르는 상기 위험 약액의 유속을 저감하도록 구성되는 유속 저감부를 포함하는, 위험 약액 주입용 플러싱 장치.And a flow rate reducing section that is disposed on an upstream side of the connection point in the first flow path and configured to reduce a flow rate of the hazardous liquid flowing in the first flow path. 제1항에 있어서,The method according to claim 1, 상기 메인 바디는 일체로 형성된 조인트 파트를 포함하고,Wherein the main body includes a joint part integrally formed therewith, 상기 조인트 파트는, 상기 유속 저감부의 하류 측 말단으로부터 상기 연결 지점까지 연결하는, 상기 제1 유로의 일 부분인 연결 유로를 형성하는, 위험 약액 주입용 플러싱 장치.Wherein the joint part forms a connection flow path which is a part of the first flow path connecting the downstream end of the flow rate reduction part to the connection point. 제2항에 있어서,3. The method of claim 2, 상기 메인 바디는, 상기 조인트 파트에 결합되어 상기 조인트 파트와 함께 상기 유속 저감부를 내부에 수용하는 커버 파트를 포함하는, 위험 약액 주입용 플러싱 장치.Wherein the main body includes a cover part coupled to the joint part to receive the flow rate reduction part together with the joint part. 제2항에 있어서,3. The method of claim 2, 상기 연결 유로는, 상기 연결 지점으로부터 상기 제1 유로의 하류 측 말단까지 연결하는, 상기 제1 유로의 일 부분인 하류 유로부보다 짧은, 위험 약액 주입용 플러싱 장치.Wherein the connecting flow path is shorter than the downstream flow path portion which is a part of the first flow path connecting from the connection point to the downstream end of the first flow path. 제1항에 있어서,The method according to claim 1, 상기 플러싱부는, 상기 제2 유로 내로 플러싱용 액체를 유입시키기 위한 플러싱 포트를 형성하는, 위험 약액 주입용 플러싱 장치.Wherein the flushing portion forms a flushing port for introducing the flushing liquid into the second flow path. 제5항에 있어서,6. The method of claim 5, 상기 제2 유로 내에서 상기 플러싱용 액체의 상기 플러싱 포트 방향으로의 역류를 방지하는 역류 방지부를 더 포함하는, 위험 약액 주입용 플러싱 장치.Further comprising a backflow prevention portion for preventing backflow of the flushing liquid in the direction of the flushing port in the second flow path. 제6항에 있어서,The method according to claim 6, 상기 역류 방지부의 적어도 일부는 상기 연결 지점에 배치되는, 위험 약액 주입용 플러싱 장치.And at least a part of the backflow prevention portion is disposed at the connection point. 제7항에 있어서,8. The method of claim 7, 상기 역류 방지부는 상기 제2 유로로부터 상기 제1 유로 내로 돌출된 돌출부를 포함하고,Wherein the backflow prevention portion includes a protrusion protruding from the second flow path into the first flow path, 상기 돌출부의 말단에 상기 플러싱용 액체가 통과하기 위한 홀이 형성된, 위험 약액 주입용 플러싱 장치.And a hole through which the liquid for flushing passes is formed at an end of the projecting portion. 제6항에 있어서,The method according to claim 6, 상기 플러싱부에 결합되고, 외부로부터 누름시 개방되는 홀을 형성하는 표면을 포함하는 플러싱 밸브 유닛을 더 포함하는, 위험 약액 주입용 플러싱 장치.Further comprising a flushing valve unit coupled to the flushing portion, the flushing valve unit including a surface defining a hole that is opened when pressed from the outside. 제5항에 있어서,6. The method of claim 5, 상기 플러싱부에 분리 가능하게 결합되고, 상기 제2 유로 내에 프라이밍용 액체가 상기 플러싱 포트 방향으로 흐름 시, 기체를 배출시키되 상기 프라이밍용 액체의 배출을 차단하는 플러싱 벤트 캡을 더 포함하는, 위험 약액 주입용 플러싱 장치.Further comprising a flushing cap cap detachably coupled to the flushing portion and configured to discharge the gas when the priming liquid flows in the direction of the flushing port in the second flow path and shut off the discharge of the priming liquid. Flushing device for injection. 제10항에 있어서,11. The method of claim 10, 상기 플러싱 벤트 캡과 교체 가능하게 상기 플러싱부에 결합되도록 구성되고, 외부로부터 누름시 개방되는 홀을 형성하는 표면을 포함하는 플러싱 밸브 유닛을 더 포함하는, 위험 약액 주입용 플러싱 장치.Further comprising a flushing valve unit configured to be coupled to the flushing portion to be replaceable with the flushing vent cap, the flushing valve unit including a surface forming a hole that is opened when pressed from the outside. 제1항에 있어서,The method according to claim 1, 상기 메인 바디는 상기 제1 유로 중 상기 연결 지점의 하류 측 부분을 형성하는 하류부를 포함하고,Wherein the main body includes a downstream portion that forms a downstream portion of the connection point in the first flow path, 상기 하류부에 배치되고, 상기 환자 연결 모듈과 분리 가능하게 결합되는 교체 결합부; 및A replacement coupling portion disposed at the downstream portion and detachably coupled to the patient connection module; And 상기 교체 결합부에 상기 환자 연결 모듈 대신 분리 가능하게 결합되고, 상기 제1 유로 내에서 프라이밍용 액체가 상기 연결 지점으로부터 상기 하류부를 따라 흐를 때, 기체를 배출시키되 상기 프라이밍용 액체의 배출을 차단하는 하류 벤트 캡을 더 포함하는, 위험 약액 주입용 플러싱 장치.Wherein when the priming liquid flows along the downstream portion from the connection point in the first flow path, the gas is discharged and the discharge of the priming liquid is blocked Further comprising a downstream vent cap. 외부 공기에 노출 시 인체에 유해한 위험 약액을 주입하기 위한 위험 약액 주입 장치에 있어서,1. A dangerous chemical liquid injecting apparatus for injecting a dangerous chemical liquid which is harmful to a human body when exposed to outside air, 상기 위험 약액을 가압하도록 구성된 펌핑 모듈;A pumping module configured to pressurize the hazardous liquid; 상기 펌핑 모듈에서의 가압에 따라 상기 펌핑 모듈로부터 유출되는 상기 위험 약액이 흐르는 연결 관; 및A connection pipe through which the dangerous chemical liquid flowing out from the pumping module flows according to the pressure in the pumping module; And 상기 연결 관과 상기 위험 약액을 환자에게 주입하기 위한 환자 연결 모듈을 연결하도록 구성되는 플러싱 장치를 포함하고,And a flushing device configured to connect the connection tube and a patient connection module for injecting the hazardous liquid into the patient, 상기 플러싱 장치는,Wherein the flushing device comprises: 상기 연결 관으로부터 유출되는 상기 위험 약액을 상기 환자 연결 모듈로 안내하는 제1 유로를 형성하고, 상기 제1 유로의 양단 사이에 위치하는 소정의 연결 지점에 연결되는 제2 유로를 형성하는 플러싱부를 구비하는 메인 바디; 및A first flow path for guiding the dangerous chemical liquid flowing out from the connection pipe to the patient connection module and a flushing part for forming a second flow path connected to a predetermined connection point located between both ends of the first flow path Main body; And 상기 제1 유로에서 상기 제2 유로의 연결 지점보다 상류 측에 배치되고, 상기 제1 유로 내에 흐르는 상기 위험 약액의 유속을 저감하도록 구성되는 유속 저감부를 포함하는, 위험 약액 주입 장치.And a flow rate reducing section that is disposed on an upstream side of a connection point of the second flow path in the first flow path and configured to reduce a flow rate of the hazardous liquid flowing in the first flow path. 제13항에 있어서,14. The method of claim 13, 상기 메인 바디는 일체로 형성된 조인트 파트를 포함하고,Wherein the main body includes a joint part integrally formed therewith, 상기 조인트 파트는, 상기 유속 저감부의 하류 측 말단으로부터 상기 연결 지점까지 연결하는, 상기 제1 유로의 일 부분인 연결 유로를 형성하는, 위험 약액 주입 장치.Wherein the joint part forms a connection flow path which is a part of the first flow path connecting the downstream end of the flow rate reduction part to the connection point. 제13항에 있어서,14. The method of claim 13, 상기 펌핑 모듈은 상기 위험 약액을 수용 가능하도록 구성된 챔버를 포함하고,Wherein the pumping module comprises a chamber configured to receive the hazardous chemical liquid, 상기 연결 관 또는 상기 챔버에 연결되어, 상기 챔버 내로 액체를 충전 가능하도록 구성된 포트 모듈을 더 포함하는, 위험 약액 주입 장치.Further comprising a port module connected to the connector or the chamber, the port module being configured to be able to fill the liquid into the chamber.
PCT/KR2018/010470 2017-10-20 2018-09-07 Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid Ceased WO2019078487A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201880068051.4A CN111225709B (en) 2017-10-20 2018-09-07 Flushing device for injecting hazardous chemical liquid and hazardous chemical liquid injection device
US16/757,114 US11464898B2 (en) 2017-10-20 2018-09-07 Flushing apparatus for injection of hazardous medicinal liquid, and hazardous medicinal liquid injection apparatus
EP18868322.1A EP3698842A4 (en) 2017-10-20 2018-09-07 Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid
JP2020542512A JP6967159B2 (en) 2017-10-20 2018-09-07 Flushing device for injecting dangerous chemicals and injecting dangerous chemicals
IL274030A IL274030B2 (en) 2017-10-20 2018-09-07 A flushing device for injecting a hazardous medical liquid and a device for injecting a hazardous medical liquid

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2017-0136432 2017-10-20
KR20170136432 2017-10-20
KR10-2018-0026509 2018-03-06
KR1020180026509A KR102168021B1 (en) 2017-10-20 2018-03-06 Flushing device for injecting dangerous drug solution and Dangerous drug solution injection device

Publications (2)

Publication Number Publication Date
WO2019078487A2 true WO2019078487A2 (en) 2019-04-25
WO2019078487A3 WO2019078487A3 (en) 2019-06-13

Family

ID=66173822

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/010470 Ceased WO2019078487A2 (en) 2017-10-20 2018-09-07 Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid

Country Status (1)

Country Link
WO (1) WO2019078487A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114585401A (en) * 2019-10-18 2022-06-03 金镕玄 Chemical liquid injection device and chemical liquid injection preparation method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200201601Y1 (en) * 2000-06-12 2000-11-01 방영철 Syringe connecting plug
US20090306621A1 (en) * 2008-02-06 2009-12-10 Gale H. Thome, JR. Vial transfer convenience IV kits and methods
US20110276031A1 (en) * 2010-05-06 2011-11-10 Becton, Dickinson And Company Systems and methods for providing a closed venting hazardous drug iv set
KR101424934B1 (en) * 2013-07-22 2014-08-04 고려대학교 산학협력단 Branch tube for injection set
KR101651092B1 (en) * 2014-09-05 2016-08-29 주식회사 제이엠메디칼 device for regulating the Injection-volume and Injection Direction of liquid medicine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114585401A (en) * 2019-10-18 2022-06-03 金镕玄 Chemical liquid injection device and chemical liquid injection preparation method
JP2022553172A (en) * 2019-10-18 2022-12-22 ヨンヒョン キム Chemical injection device and chemical injection preparation method

Also Published As

Publication number Publication date
WO2019078487A3 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
WO2016186272A1 (en) Filter structure for syringe and syringe including same
EP3698842A2 (en) Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid
RU2667823C2 (en) Device for filling syringe with gas and method of manufacture and use thereof
WO2016190526A1 (en) Filter needle assembly for syringe
WO2010090418A2 (en) Filter device and syringe incorporating same
US20060163514A1 (en) Valved male luer with vacuum feature
WO2010120051A2 (en) Drug filling and flow control apparatus, and drug injection apparatus comprising same
TR201803000T4 (en) Valve connection for medical lines.
WO2017159923A1 (en) Filter assembly for syringe, and syringe and ringer assembly comprising same
KR20110067017A (en) Closed male luer unit to minimize leakage when connecting and disconnecting
WO2019045247A1 (en) Microjet drug injection device equipped with backflow prevention valve
WO2017131370A1 (en) Syringe
WO2017217692A1 (en) Reuse-prevention disposable syringe
WO2019078487A2 (en) Flushing apparatus for injecting hazardous medical liquid, and apparatus for injecting hazardous medical liquid
WO2017074040A1 (en) Filter syringe
WO2016195277A1 (en) Filtering needle provided with slidingly detachable intake tube, and filtering syringe
WO2017209378A1 (en) Outer cap of medicinal fluid injection instrument
WO2017078322A1 (en) Syringe
WO2020027507A1 (en) End cap for medical liquid injection apparatus and medical liquid injection apparatus set
WO2017034080A1 (en) Syringe filter structure and syringe including same
WO2015125987A1 (en) Syringe integrated with filter needle, blood backflow prevention device and venous catheter having blood backflow prevention device
WO2014051217A1 (en) Medical catheter
WO2020080889A1 (en) Air filter for medicinal liquid injection and medicinal liquid injection apparatus including the same
EP3866882A1 (en) Air filter for medicinal liquid injection and medicinal liquid injection apparatus including the same
WO2021075900A1 (en) Chemical solution injection device and chemical solution injection preparing method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18868322

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2020542512

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018868322

Country of ref document: EP

Effective date: 20200520